# US 2025/0154528 A1 · Adeno-associated viral vectors and uses thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0154528 A1
- Document ID: US20250154528A1
- Status: Published application
- Kind: A1
- Application number: 18/834,583
- Filed: 2023-01-31
- Published: 2025-05-15
- Earliest claimed: 2022-02-01
- Assignees: The Broad Institute, Inc.
- Applicants: The Broad Institute, Inc.
- Inventors: Ken Y. CHAN; Benjamin E. DEVERMAN; FatmaElzahraa Abdelmouty EID
- Web page: https://patentgrep.com/patent/US20250154528A1

## CPC

- C12N 15/86: Viral vectors
- C07K 14/005: from viruses
- C12N 15/1034: {Isolating an individual clone by screening libraries}
- C40B 40/08: Libraries containing RNA or DNA which encodes proteins, e.g. gene libraries
- C40B 40/10: Libraries containing peptides or polypeptides, or derivatives thereof
- C12N 2750/14122: New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C12N 2750/14143: viral genome or elements thereof as genetic vector
- C12N 2750/14145: Special targeting system for viral vectors
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C40B: COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES (in silico combinatorial libraries of nucleic acids, proteins or peptides G16B35/00; in silico combinatorial chemistry G16C20/60)

## Abstract

The invention provides adeno-associated viral vectors and methods of using such vectors for cell transduction.

## Claims

### Claim 1

An adeno-associated virus (AAV) capsid polypeptide comprising a peptide inserted within the capsid polypeptide, wherein the peptide comprises an amino acid sequence selected from the group consisting of RPNRDTS (SEQ ID NO: 144800); MDGQRRI (SEQ ID NO: 132518); ETNRAGR (SEQ ID NO: 116028); TGRVDSR (SEQ ID NO: 149619); NMTRARD (SEQ ID NO: 136472); GEKPKFT (SEQ ID NO: 164722); MEPRQRT (SEQ ID NO: 132640); and variants thereof comprising a substitution or deletion of one or two amino acids.

### Claim 2 (depends on 1)

The capsid polypeptide of claim 1, wherein the capsid is an AAV1, AAV2, AAV3, AAV3b, AAV4, AAV5, AAV6, AAV7, AAV8, AAV9, AAV9 K449R, rh.10, rh.8, or LK03 capsid polypeptide.

### Claim 3 (depends on 1)

The capsid polypeptide of claim 1,
wherein the peptide is inserted in Loop VIII of the capsid polypeptide;
wherein the peptide is inserted between amino acids 565 and 605 of an AAV9 K449R amino acid sequence, or at an equivalent insertion position in another AAV polypeptide;
wherein the peptide is inserted between amino acids 575 and 595 and 600 of an AAV9 K449R amino acid sequence, or at an equivalent insertion position in another AAV polypeptide;
and/or wherein the peptide is inserted between amino acids 588 and 589 of an AAV9 K449R amino acid sequence, or at an equivalent insertion position in another AAV polypeptide.

### Claim at position 4

4-6. (canceled)

### Claim 7 (depends on 1)

The capsid polypeptide of claim 1, wherein a viral particle comprising an AAV capsid comprising the peptide has increased transduction efficiency for a cell of interest relative to an AAV capsid lacking the peptide.

### Claim 8 (depends on 7)

The capsid polypeptide of claim 7, wherein the cell of interest is a liver cell, brain cell, brain endothelial cell, kidney cell, spinal cord cell, spleen cell, nerve cell, or a cell of the spinal cord, heart, or lungs.

### Claim 9 (depends on 7)

The capsid polypeptide of claim 7, wherein transduction efficiency is increased by at least about 10%, 25%, 50%, 100%, 200% or more relative to an AAV capsid lacking the peptide.

### Claim 10 (depends on 1)

The capsid polypeptide of claim 1, wherein a viral particle comprising an AAV capsid comprising the peptide has increased production fitness relative to an AAV capsid lacking the peptide; and/or wherein a viral particle comprising an AAV capsid comprising the peptide has increased biodistribution in an organ of interest relative to an AAV capsid lacking the peptide.

### Claim at position 9

11-13. (canceled)

### Claim 14

An adeno-associated virus (AAV) capsid polypeptide comprising a peptide inserted within the capsid polypeptide, wherein the peptide comprises a motif selected from those listed in Tables 2-27.

### Claim 15 (depends on 8)

The capsid polypeptide of claim 8, wherein the AAV capsid polypeptide is an AAV9 K449R capsid polypeptide and shares at least 85% sequence identity to an amino acid sequence selected from the group consisting of:
AAV-BI151
(SEQ ID NO: 199456)
MAADGYLPDWLEDNLSEGIREWWALKPGAPQPKANQQHQDNARGLVLPGYKYLGPGNGLDKGEP
VNAADAAALEHDKAYDQQLKAGDNPYLKYNHADAEFQERLKEDTSFGGNLGRAVFQAKKRLLEP
LGLVEEAAKTAPGKKRPVEQSPQEPDSSAGIGKSGAQPAKKRLNFGQTGDTESVPDPQPIGEPP
AAPSGVGSLTMASGGGAPVADNNEGADGVGSSSGNWHCDSQWLGDRVITTSTRTWALPTYNNHL
YKQISNSTSGGSSNDNAYFGYSTPWGYFDENRFHCHESPRDWQRLINNNWGFRPKRLNFKLFNI
QVKEVTDNNGVKTIANNLTSTVQVFTDSDYQLPYVLGSAHEGCLPPFPADVEMIPQYGYLTLND
GSQAVGRSSFYCLEYFPSQMLRTGNNFQFSYEFENVPFHSSYAHSQSLDRLMNPLIDQYLYYLS
RTINGSGQNQQTLKFSVAGPSNMAVQGRNYIPGPSYRQQRVSTTVTQNNNSEFAWPGASSWALN
GRNSLMNPGPAMASHKEGEDRFFPLSGSLIFGKQGTGRDNVDADKVMITNEEEIKTTNPVATES
YGQVATNHQSAQRPNRDTSAQAQTGWVQNQGILPGMVWQDRDVYLQGPIWAKIPHTDGNFHPSP
LMGGFGMKHPPPQILIKNTPVPADPPTAFNKDKLNSFITQYSTGQVSVEIEWELQKENSKRWNP
EIQYTSNYYKSNNVEFAVNTEGVYSEPRPIGTRYLTRNL;
AAV-BI152
(SEQ ID NO: 199457)
MAADGYLPDWLEDNLSEGIREWWALKPGAPQPKANQQHQDNARGLVLPGYKYLGPGNGLDKGEP
VNAADAAALEHDKAYDQQLKAGDNPYLKYNHADAEFQERLKEDTSFGGNLGRAVFQAKKRLLEP
LGLVEEAAKTAPGKKRPVEQSPQEPDSSAGIGKSGAQPAKKRLNFGQTGDTESVPDPQPIGEPP
AAPSGVGSLTMASGGGAPVADNNEGADGVGSSSGNWHCDSQWLGDRVITTSTRTWALPTYNNHL
YKQISNSTSGGSSNDNAYFGYSTPWGYFDFNRFHCHESPRDWQRLINNNWGFRPKRLNFKLFNI
QVKEVTDNNGVKTIANNLTSTVQVFTDSDYQLPYVLGSAHEGCLPPFPADVFMIPQYGYLTLND
GSQAVGRSSFYCLEYFPSQMLRTGNNFQFSYEFENVPFHSSYAHSQSLDRLMNPLIDQYLYYLS
RTINGSGQNQQTLKFSVAGPSNMAVQGRNYIPGPSYRQQRVSTTVTQNNNSEFAWPGASSWALN
GRNSLMNPGPAMASHKEGEDRFFPLSGSLIFGKQGTGRDNVDADKVMITNEEEIKTTNPVATES
YGQVATNHQSAQMDGQRRIAQAQTGWVQNQGILPGMVWQDRDVYLQGPIWAKIPHTDGNFHPSP
LMGGFGMKHPPPQILIKNTPVPADPPTAFNKDKLNSFITQYSTGQVSVEIEWELQKENSKRWNP
EIQYTSNYYKSNNVEFAVNTEGVYSEPRPIGTRYLTRNL;
AAV-BI153
(SEQ ID NO: 199458)
MAADGYLPDWLEDNLSEGIREWWALKPGAPQPKANQQHQDNARGLVLPGYKYLGPGNGLDKGEP
VNAADAAALEHDKAYDQQLKAGDNPYLKYNHADAEFQERLKEDTSFGGNLGRAVFQAKKRLLEP
LGLVEEAAKTAPGKKRPVEQSPQEPDSSAGIGKSGAQPAKKRLNFGQTGDTESVPDPQPIGEPP
AAPSGVGSLTMASGGGAPVADNNEGADGVGSSSGNWHCDSQWLGDRVITTSTRTWALPTYNNHL
YKQISNSTSGGSSNDNAYFGYSTPWGYFDENRFHCHESPRDWQRLINNNWGFRPKRLNFKLFNI
QVKEVTDNNGVKTIANNLTSTVQVFTDSDYQLPYVLGSAHEGCLPPFPADVEMIPQYGYLTLND
GSQAVGRSSFYCLEYFPSQMLRTGNNFQFSYEFENVPFHSSYAHSQSLDRLMNPLIDQYLYYLS
RTINGSGQNQQTLKFSVAGPSNMAVQGRNYIPGPSYRQQRVSTTVTQNNNSEFAWPGASSWALN
GRNSLMNPGPAMASHKEGEDRFFPLSGSLIFGKQGTGRDNVDADKVMITNEEEIKTTNPVATES
YGQVATNHQSAQETNRAGRAQAQTGWVQNQGILPGMVWQDRDVYLQGPIWAKIPHTDGNFHPSP
LMGGFGMKHPPPQILIKNTPVPADPPTAFNKDKLNSFITQYSTGQVSVEIEWELQKENSKRWNP
EIQYTSNYYKSNNVEFAVNTEGVYSEPRPIGTRYLTRNL;
AAV-BI154
(SEQ ID NO: 199459)
MAADGYLPDWLEDNLSEGIREWWALKPGAPQPKANQQHQDNARGLVLPGYKYLGPGNGLDKGEP
VNAADAAALEHDKAYDQQLKAGDNPYLKYNHADAEFQERLKEDTSFGGNLGRAVFQAKKRLLEP
LGLVEEAAKTAPGKKRPVEQSPQEPDSSAGIGKSGAQPAKKRLNFGQTGDTESVPDPQPIGEPP
AAPSGVGSLTMASGGGAPVADNNEGADGVGSSSGNWHCDSQWLGDRVITTSTRTWALPTYNNHL
YKQISNSTSGGSSNDNAYFGYSTPWGYFDENRFHCHESPRDWQRLINNNWGFRPKRLNFKLENI
QVKEVTDNNGVKTIANNLTSTVQVFTDSDYQLPYVLGSAHEGCLPPFPADVEMIPQYGYLTLND
GSQAVGRSSFYCLEYFPSQMLRTGNNFQFSYEFENVPFHSSYAHSQSLDRLMNPLIDQYLYYLS
RTINGSGQNQQTLKFSVAGPSNMAVQGRNYIPGPSYRQQRVSTTVTQNNNSEFAWPGASSWALN
GRNSLMNPGPAMASHKEGEDRFFPLSGSLIFGKQGTGRDNVDADKVMITNEEEIKTTNPVATES
YGQVATNHQSAQTGRVDSRAQAQTGWVQNQGILPGMVWQDRDVYLQGPIWAKIPHTDGNFHPSP
LMGGFGMKHPPPQILIKNTPVPADPPTAFNKDKLNSFITQYSTGQVSVEIEWELQKENSKRWNP
EIQYTSNYYKSNNVEFAVNTEGVYSEPRPIGTRYLTRNL;
AAV-BI155
(SEQ ID NO: 199460)
MAADGYLPDWLEDNLSEGIREWWALKPGAPQPKANQQHQDNARGLVLPGYKYLGPGNGLDKGEP
VNAADAAALEHDKAYDQQLKAGDNPYLKYNHADAEFQERLKEDTSFGGNLGRAVFQAKKRLLEP
LGLVEEAAKTAPGKKRPVEQSPQEPDSSAGIGKSGAQPAKKRLNFGQTGDTESVPDPQPIGEPP
AAPSGVGSLTMASGGGAPVADNNEGADGVGSSSGNWHCDSQWLGDRVITTSTRTWALPTYNNHL
YKQISNSTSGGSSNDNAYFGYSTPWGYFDENRFHCHFSPRDWQRLINNNWGFRPKRLNFKLFNI
QVKEVTDNNGVKTIANNLTSTVQVFTDSDYQLPYVLGSAHEGCLPPFPADVEMIPQYGYLTLND
GSQAVGRSSFYCLEYFPSQMLRTGNNFQFSYEFENVPFHSSYAHSQSLDRLMNPLIDQYLYYLS
RTINGSGQNQQTLKFSVAGPSNMAVQGRNYIPGPSYRQQRVSTTVTQNNNSEFAWPGASSWALN
GRNSLMNPGPAMASHKEGEDRFFPLSGSLIFGKQGTGRDNVDADKVMITNEEEIKTTNPVATES
YGQVATNHQSAQNMTRARDAQAQTGWVQNQGILPGMVWQDRDVYLQGPIWAKIPHTDGNFHPSP
LMGGFGMKHPPPQILIKNTPVPADPPTAFNKDKLNSFITQYSTGQVSVEIEWELQKENSKRWNP
EIQYTSNYYKSNNVEFAVNTEGVYSEPRPIGTRYLTRNL;
AAV-BI156
(SEQ ID NO: 199461)
MAADGYLPDWLEDNLSEGIREWWALKPGAPQPKANQQHQDNARGLVLPGYKYLGPGNGLDKGEP
VNAADAAALEHDKAYDQQLKAGDNPYLKYNHADAEFQERLKEDTSFGGNLGRAVFQAKKRLLEP
LGLVEEAAKTAPGKKRPVEQSPQEPDSSAGIGKSGAQPAKKRLNFGQTGDTESVPDPQPIGEPP
AAPSGVGSLTMASGGGAPVADNNEGADGVGSSSGNWHCDSQWLGDRVITTSTRTWALPTYNNHL
YKQISNSTSGGSSNDNAYFGYSTPWGYFDFNRFHCHFSPRDWQRLINNNWGFRPKRLNFKLENI
QVKEVTDNNGVKTIANNLTSTVQVFTDSDYQLPYVLGSAHEGCLPPFPADVEMIPQYGYLTLND
GSQAVGRSSFYCLEYFPSQMLRTGNNFQFSYEFENVPFHSSYAHSQSLDRLMNPLIDQYLYYLS
RTINGSGQNQQTLKFSVAGPSNMAVQGRNYIPGPSYRQQRVSTTVTQNNNSEFAWPGASSWALN
GRNSLMNPGPAMASHKEGEDRFFPLSGSLIFGKQGTGRDNVDADKVMITNEEEIKTTNPVATES
YGQVATNHQSAQGEKPKFTAQAQTGWVQNQGILPGMVWQDRDVYLQGPIWAKIPHTDGNFHPSP
LMGGFGMKHPPPQILIKNTPVPADPPTAFNKDKLNSFITQYSTGQVSVEIEWELQKENSKRWNP
EIQYTSNYYKSNNVEFAVNTEGVYSEPRPIGTRYLTRNL;
and
AAV-BI157
(SEQ ID NO: 199462)
MAADGYLPDWLEDNLSEGIREWWALKPGAPQPKANQQHQDNARGLVLPGYKYLGPGNGLDKGEP
VNAADAAALEHDKAYDQQLKAGDNPYLKYNHADAEFQERLKEDTSFGGNLGRAVFQAKKRLLEP
LGLVEEAAKTAPGKKRPVEQSPQEPDSSAGIGKSGAQPAKKRLNFGQTGDTESVPDPQPIGEPP
AAPSGVGSLTMASGGGAPVADNNEGADGVGSSSGNWHCDSQWLGDRVITTSTRTWALPTYNNHL
YKQISNSTSGGSSNDNAYFGYSTPWGYFDFNRFHCHFSPRDWQRLINNNWGFRPKRLNFKLENI
QVKEVTDNNGVKTIANNLTSTVQVFTDSDYQLPYVLGSAHEGCLPPFPADVEMIPQYGYLTLND
GSQAVGRSSFYCLEYFPSQMLRTGNNFQFSYEFENVPFHSSYAHSQSLDRLMNPLIDQYLYYLS
RTINGSGQNQQTLKFSVAGPSNMAVQGRNYIPGPSYRQQRVSTTVTQNNNSEFAWPGASSWALN
GRNSLMNPGPAMASHKEGEDRFFPLSGSLIFGKQGTGRDNVDADKVMITNEEEIKTTNPVATES
YGQVATNHQSAQMEPRQRTAQAQTGWVQNQGILPGMVWQDRDVYLQGPIWAKIPHTDGNFHPSP
LMGGFGMKHPPPQILIKNTPVPADPPTAFNKDKLNSFITQYSTGQVSVEIEWELQKENSKRWNP
EIQYTSNYYKSNNVEFAVNTEGVYSEPRPIGTRYLTRNL*.

### Claim 16 (depends on 8)

A viral particle comprising the AAV capsid polypeptide of claim 8.

### Claim 17 (depends on 1)

A polynucleotide encoding the capsid polypeptide of claim 1.

### Claim 18 (depends on 1)

A library of adeno-associated virus (AAV) capsid polypeptides or polynucleotides encoding the same, wherein the library comprises two or more capsid polypeptides of claim 1; or wherein the library comprises two or more capsid polypeptides each comprising a peptide with a sequence selected from the group consisting of SEQ ID NOs: 1-199427 and 200028-201544.

### Claim at position 15

19-25. (canceled)

### Claim 26 (depends on 12)

The library of claim 12, wherein the capsid is an AAV1, AAV2, AAV3, AAV3b, AAV4, AAV5, AAV6, AAV7, AAV8, AAV9, AAV9 K449R, rh.10, rh.8, or LK03 capsid polypeptide.

### Claim 27

(canceled)

### Claim 28 (depends on 12)

The library of claim 12, wherein the library comprises an amino acid sequence motif selected from the group consisting of:
[RQMT] [RNQP] [RQPS] [ANQGST] **G; [QTV] [ANQGKP] [RNGSTY] * [ARGT] * [GP];
[RKSV] [FPS] ** [RT] [QGS] [GS]; [GST] * [QT] [NQ]R*G; [TV] ** [NS]R[QGM]G;
[RNQT] [ANPS] [RNS] ** [NQGS]G; T [NGS] **R[AQS]G; NR** [NG] [QG]A;
R**QGGG (SEQ ID NO: 199501); [QF] [KS] [RN] ** [NP] [AP]; QR**S [TV]A (SEQ ID NO: 199502); [QKM] *G[RSV] [KT] *G;
[QMTV] [RN] * [ANV] [RQS] * [GS]; [NQ]R[NGP] [NQS] **A;
[QT] * [RT] [RT] * [NQG] [AG]; NTR**SA (SEQ ID NO: 199503);
QRP* [AS] * [AS]; RQ**TNA (SEQ ID NO: 199504); QRP** [MV] [AS];
[RN] *N[RS] *[QG]G; [MTV]R[PS] *[QT] *G; [RY]S*[QK] *Q[GS]; MRG**MG (SEQ ID NO: 199505); [GV] *[NT] *R[QS]G; [ST] [RQ] [RS]T**A; R*S*STP (SEQ ID NO: 199506); QR**TNG (SEQ ID NO: 199507); Q*RQT*P (SEQ ID NO: 199508); [NQ]RQ*[GS] *A; TR**NNA (SEQ ID NO: 199509);
[RT]S*[RQ] [QS] *A; GQ*RV*G (SEQ ID NO: 199510); T*TSR*G (SEQ ID NO: 199511); TRG**TG (SEQ ID NO: 199512); NR* [GT] * [TV]G; T*RT*SA (SEQ ID NO: 199513); MG*R*GA (SEQ ID NO: 199514); [NQ]R*[NQ]S*A;
RQ*PT*A (SEQ ID NO: 199515); T*T*RSG (SEQ ID NO: 199516); T*RGS*P (SEQ ID NO: 199517); TR**TMG (SEQ ID NO: 199518); R*TS*SP (SEQ ID NO: 199519); N**QRSA (SEQ ID NO: 199520); [QT] [RK] *S* [TY]A;
QR*PA*G (SEQ ID NO: 199521); RS*S*GG (SEQ ID NO: 199522); RTS*S*P (SEQ ID NO: 199523); TRQ*T*G (SEQ ID NO: 199524); QR*S*TG (SEQ ID NO: 199525); R*NS*SP (SEQ ID NO: 199526); MR*G*QS (SEQ ID NO: 199527); N**SRQG (SEQ ID NO: 199528); NR*ST*A (SEQ ID NO: 199529);
RSQ*G*G (SEQ ID NO: 199530); T*RTN*A (SEQ ID NO: 199531); T*S*RMG (SEQ ID NO: 199532); TR**TQA (SEQ ID NO: 199533); and TRT**SG (SEQ ID NO: 199534); YSGK**G (SEQ ID NO: 199535); or polynucleotides encoding the same, where “*” represents any amino acid and square brackets denote a list of amino acids that may occur at a position; and/or
wherein the library comprises an amino acid sequence motif selected from the group consisting of: [RQGKST] [ARNQGFPST] ** [ARNQGKMTV] [ANQGMSV]G;
[{circumflex over ( )}ADCEHILKPW] [ARNQGKPS] [ARNQGKST] [ARNQKPSTV] **[NDGPS];
[NQKMFSTY] [RNGKT] [{circumflex over ( )}CEHILKFSWY] ** [RNQKMPSTV] [ANDEPS];
[{circumflex over ( )}ARDCEHILW] [RGLKPSY] * [NQGKPSTV] * [ANQGFST]G;
[{circumflex over ( )}ARDCEHILPW] [ARQGKPT] [RQGKPST] ** [ANGMST]G;
[{circumflex over ( )}ADCQEHILW] [NQGLKMPST] * [{circumflex over ( )}NCEHILMFWY] [ARNQGMTV] * [GS];
[RGMY] [ANQGPS] [NQKPST] ** [ANGKMST]G;
[NQGKFSTV] [RNQGKS] ** [ARNGKT] [NQGKFSYV] [ANDGS];
[{circumflex over ( )}ARDCEHILFW] * [ARNQGKMPT] [RQGKPSTV] * [AQGST]G;
[{circumflex over ( )}ARDCEHILPW] * [RNGKPST] * [ARNGKSV] [NQGKMST]G;
[RNKT] [RNQPS] *[RQGPS] [RQGS] *[APS];
[RNMPY] [RNQKPS] * [ANQTV] * [ANQGKTV] [DGPS];
[NQGKMFTV] [ARQGKMPTV] [RNQGKPTY] * [ARQKMST] *G;
[RNQMFST] [RNQGKT] *[ARNQPST] *[AQGSTY] [APS];
[QGKMSTV] * [ARNQGKMPT] [RNQGKT] [ARNSTV] *G;
[RMT] * [NQKT] * [ARQGT] [ANQS] [GP];
[RKMSV] **L[ANQGKPS] [NGMSTV] [ANGKSTV] [DGS];
[NQKMPTYV] * [ARGKPTV] [NGST] [RNQKST] * [GPS];
[RNQKMSY] [RQKST] [ADQKPST] * [AKSTV] * [ADPS]; [RK] ** [NG] [AS] [GT]A;
[RQ] * [RNPST] [AQGST] [AQGSTV] * [GPS]; R[QPS] *S* [QGV]G;
[RKV] [NGKP] *N[ANGT] *G; [NQGLKFT] [NGKS] [QKMS] ** [ARQKSV] [ANDEG];
[RQMS] * [RNQKST] [NPST] * [ARNQGMS] [DGP]; [RKT] ** [PST] [QT] [ANG]G;
[NQKMT] [ARDKPST] [RNGKP] *G*G;
[RNQKMFT] [RDGKPST] [RNQGKPT] *[NQGST] *[AS];
[RNQMST] [RNDQKST] [RGKPST] [AQGKPST] **[APSV];
[QKT] * [KS] * [AQGS] [NQS] [AS]; [KFV] * [ANK] * [ST] [KS] [AD];
[RQKMTYV] [RNDKPS] [RQGPS] [NDQGPST] ** [GP];
[NQMT]R*[NGPTV] [AQGS] *[GS]; [QMSY] [RKP] **S[AQGKV] [ADGS];
R[NS] ** [ANQ] [AQT]A; R[QS] **T [NQ] [AS]; [RQ] * [KPT] [GST] * [ANQGT]G;
[RN] [RQP] * [GPS]T*A; [RNMPT] * [RNGKST] [ANDQKPST] [RNGST] *A;
K[QPS] *[NMS] *[QV] [GS]; K*[NQG] *[NT] [AST]G; RN*Q*SG (SEQ ID NO: 199536); K* [ANGST] [NST] * [AMS] [GS]; KT*S*GA (SEQ ID NO: 199537);
[RKMT] [RQKPST]S*[ARSTV] *G; [KM] *N*GNA (SEQ ID NO: 199538);
N**S [GT] [GM]A; K* [GPS] [GT] [AT] *A; [QG]K* [GTV] [AMS] * [AN];
[RQT] * [RNQPT] [RNST] * [QGS]A; [NQ] [RK] ** [GS]TA; [TV] **NRQG (SEQ ID NO: 199539); R[AGPS] [NQPT] *[NGST] *G; R[MST]N**[QT] [GP];
[RNQ] * [PT] [GT] [RS] *A; RS**NTG (SEQ ID NO: 199540);
[RK] *[PS]G*[NQGT]A; Q*KSA*A (SEQ ID NO: 199541); KN*G*TA (SEQ ID NO: 199542); K*S*[AS]GA (SEQ ID NO: 199543); [NG]K*[AS] [GT] *A;
[GV]NS*[RK] *G; KT*S*SA (SEQ ID NO: 199544); [RM] [KP] *[AS]S*G;
VK**STG (SEQ ID NO: 199545); [QKT] [RQGMSTV] [AGKP] [NGST] **A;
PR*AT*G (SEQ ID NO: 199546); TRS*T*M (SEQ ID NO: 199547); T**RQQA (SEQ ID NO: 199548); KN*S*SG (SEQ ID NO: 199549); RNS*[AG] *G (SEQ ID NO: 199550); R*S* [AS]T [PS]; [RG] [KS]S* [GT] * [AG]; QR*NS*A (SEQ ID NO: 199551); R*SN*TG (SEQ ID NO: 199552); R*[NS] *[GT]GG;
RAP**NS (SEQ ID NO: 199553); R*NNS*G (SEQ ID NO: 199554);
[NK] * [GKP] [GST] * [GS]A; QK*GT*G (SEQ ID NO: 199555); T**NRGG (SEQ ID NO: 199556); VK*AS*A (SEQ ID NO: 199557); K*P*TGG (SEQ ID NO: 199558); K**QNQG (SEQ ID NO: 199559); R*S*TAP (SEQ ID NO: 199560);
K*S[NG] *[GS] [GS]; R*SN*NA (SEQ ID NO: 199561); RMP**GA (SEQ ID NO: 199562); [RW] [ANP]N[AKS] **A; KT**SGG (SEQ ID NO: 199563); R*P*TGA (SEQ ID NO: 199564); N**QRSA (SEQ ID NO: 199520); K*[NQ]ST*A (SEQ ID NO: 199565); MKN[TV] **A (SEQ ID NO: 199566); KGNN**G (SEQ ID NO: 199567); TKP**AA (SEQ ID NO: 199568); TR*GT*G (SEQ ID NO: 199569); KN*G*SA (SEQ ID NO: 199570); K*ASS*A (SEQ ID NO: 199571);
KLNS**G (SEQ ID NO: 199572); N**SRQG (SEQ ID NO: 199528); and
QNR*A*P (SEQ ID NO: 199573); R*P*AGA (SEQ ID NO: 199574); RT**STP (SEQ ID NO: 199575); SRTT*NG (SEQ ID NO: 199576); T*RT*NA (SEQ ID NO: 199577); TK*NS*G (SEQ ID NO: 199578); TRP**AA (SEQ ID NO: 199579); or polynucleotides encoding the same, where “*” represents any amino acid, square brackets surrounding a list of amino acids not preceded by the symbol “{circumflex over ( )}” denote a list of amino acids that may occur at a position, and square brackets surrounding a list of amino acids preceded by the symbol “{circumflex over ( )}” denote a list of amino acids that may not occur at a position.

### Claim 29

(canceled)

### Claim 30

The library 14, wherein a viral particle having a capsid comprising the motif has increased binding to a cell of interest relative to a control viral particle.

### Claim 31 (depends on 14)

The library of claim 14, wherein the library comprises an amino acid sequence motif selected from the group consisting of: QSRT**P (SEQ ID NO: 199580); K[HP] [NT] *P* [NS]; RN*P*TS (SEQ ID NO: 199581); K**GPKD (SEQ ID NO: 199582); NRGQ**A (SEQ ID NO: 199583); A**NEKR (SEQ ID NO: 199584); TG**RSG (SEQ ID NO: 199585); TAN*R*G (SEQ ID NO: 199586); T*TNR*G (SEQ ID NO: 199587); QSR**NP (SEQ ID NO: 199588); T*T*RSG (SEQ ID NO: 199516); K**NPAN (SEQ ID NO: 199589); KM**PKD (SEQ ID NO: 199590); MSRN**A (SEQ ID NO: 199591); NDA**KK (SEQ ID NO: 199592); QR*GP*M (SEQ ID NO: 199593); RS*P*NA (SEQ ID NO: 199594); T*S*RMG (SEQ ID NO: 199532); T*TSR*G (SEQ ID NO: 199511); VAR* H*G (SEQ ID NO: 199595); or polynucleotides encoding the same, where “*” represents any amino acid and square brackets denote a list of amino acids that may occur at a position; and
wherein a viral particle having a capsid comprising the motif has increased binding to a liver cell relative to a control viral particle;
wherein the library comprises an amino acid sequence motif selected from the group consisting of: [GKMFSTYV] [NGKST] ** [ARNGKSV] [AQMFST]G;
[RNQKTY] *[NQGKPST] [ANGPST] *[NQGTV]G; [QLMFPSTYV]K* [GPSTV] * [QGST]G;
[RNQGKMPTY] [ARNQGPST] [ARNQGKPT] ** [AGKMSTV]G;
[RQGMTV] *[RQGKPST] [QGPST] *[ARQMPS] [DGPS];
[RNQGKMPST] * [AQGKMPSTV] [RNQGST] [ARNQGKST] *G;
[NGKTV] ** [RNQGPSTV] [ARQGKMST] [ANQGKFST] [AGPS];
[RNGKMFSTY] [ANQLKMPT] * [ARDQGSTV] [ARQGKTV] * [GS];
[RQGKMFTV] [ARNQGPST] [RGKPST] * [{circumflex over ( )}DCEILFPWY] *G;
[RNQGIKMST] [RDLKMFST] [ANDQHMPST] ** [ARNGKMSV] [ANDEKPS];
[RNQGIKFV] * [ARNQPST] * [ARGKMTV] [ARNQGT] [DEGS];
[{circumflex over ( )}ARNCEHILP] [ANQGKMPST] [RNQGHKMST] [ARNQGKPTV] ** [ARGS];
[RNQGIMFT] [RKPSTV] [AQGHKPST] *[ARNIKST] *[EGPS];
[NQKMFSTV] [RKS] **[AGST] [ARNDKSTV] [ADEK];
[RNQKMSTY] [RNGKST] * [ARNQMPSTV] * [{circumflex over ( )}CEHILKFPWV] [ADPST];
K* [GMP] [QST] * [AQM] [GS]; [RQKTY] * [ARQKPST] [QGST] [ANGST] * [ADPS];
[NQFTY] * [KST] * [ARGS] [AQGKMTV]G; [RT] [RPT] ** [ANST] [NQT] [APS];
[RNKMPY] [ARNGLKS] * [ANQKST] * [AQGSV]G; [RNQSY] [KPST] ** [RNGMS] [QG]G;
[RKT] [PS] * [RPST] [QGS] *A; [RNQEKMS] [RNQT] [RGIPST] [NQGKPT] ** [AEGFP];
[NQT]K* [AGPST] [GMS] * [AS]; [RNK] [RDLS] [RNPT]S** [GP];
[RK] * [NP] [GV] * [GT]A; [RQGMFSY] [KS] [NQGMPS] ** [NQGS] [GS];
[MFPV]K[ANPS]S**[GS]; [MF]K[NT] **[QPT]A;
[GFT] *[GKT] *[RNQK] [KSTV] [GS]; [QGM] [RKS] [NGPS] *[AST] *A;
[RT] * [KP] * [QT] [QG]A; [GM] [HP]K** [AP]A; [TV] * [NK] *S [NS] [AS];
[QGMT] [RK] * [GPTV] [AS] *G; [RV] [KP] *NT*G; M*SKS*A (SEQ ID NO: 199596); A**NEKR (SEQ ID NO: 199584); PR*AT*G (SEQ ID NO: 199546);
NK[AGP] [AQV] **[DGS]; [MS] **K[ST] [GT]G; [RQK] [ARF] **T[AGS]G;
[QF]K**[AN] [QS]S; [NMT]K[ANP] *G*G; R**KEEK (SEQ ID NO: 199597);
[RGV] [KP] *[AS] [ST] *[AS]; NK[NS] *G*A (SEQ ID NO: 200021); QK*GT*G (SEQ ID NO: 199555); TK*NS*G (SEQ ID NO: 199578); TGK**[AT]A (SEQ ID NO: 199598); R**AGVG (SEQ ID NO: 199599); [NT]K* [TV] *KD;
MKS**TG (SEQ ID NO: 199600); G*KSV*G (SEQ ID NO: 199601);
[KM] * [NS] * [GS] [NG]A; TNK**QG (SEQ ID NO: 199602);
K[DKPS] [RNDQ] *[GK] *[AD]; NAR*T*G (SEQ ID NO: 199603); MR*NQ*G (SEQ ID NO: 199604); [FT] *K[AT] *QA; KT**GGA (SEQ ID NO: 199605);
V*NKV*G (SEQ ID NO: 199606); FKG**SA (SEQ ID NO: 199607); FNK**QG (SEQ ID NO: 199608); GPK*T*A (SEQ ID NO: 199609); KQS*S*P (SEQ ID NO: 199610); [NS] *KG* [ST]A; GP*G*KG (SEQ ID NO: 199611); RDKS**A (SEQ ID NO: 199612); R*S*STP (SEQ ID NO: 199506); KT**AGG (SEQ ID NO: 199613); FK**TQG (SEQ ID NO: 199614); FGK**TG (SEQ ID NO: 199615); NKTG**A (SEQ ID NO: 199616); TK**TYG (SEQ ID NO: 199617);
TKPG**G (SEQ ID NO: 199618); KP*T*GG (SEQ ID NO: 199619); TGK**SA (SEQ ID NO: 199620); KPN*S*A (SEQ ID NO: 199621); TGKS**A (SEQ ID NO: 199622); T*RT*SA (SEQ ID NO: 199513); V*KS*TG (SEQ ID NO: 199623); F*K*TSA (SEQ ID NO: 199624); FGK**SG (SEQ ID NO: 199625);
K*GG*AG (SEQ ID NO: 199626); KPS*N*A (SEQ ID NO: 199627); QR*NS*A (SEQ ID NO: 199551); R**QGGG (SEQ ID NO: 199501); RP*N*GG (SEQ ID NO: 199628); TK**TQG (SEQ ID NO: 199629); TKSS**A (SEQ ID NO: 199630); and V*KSQ*G (SEQ ID NO: 199631); or polynucleotides encoding the same, where “*” represents any amino acid, square brackets surrounding a list of amino acids not preceded by the symbol “{circumflex over ( )}” denote a list of amino acids that may occur at a position, and square brackets surrounding a list of amino acids preceded by the symbol “{circumflex over ( )}” denote a list of amino acids that may not occur at a position, wherein a viral particle having a capsid comprising the motif has increased transduction efficiency for a liver cell relative to a control viral particle;
wherein the library comprises an amino acid sequence motif selected from the group consisting of: [ARDTV] ** [NKP] [REG] [QEGK] [RGK]; NAR**GG (SEQ ID NO: 199632); N[AR] [RG]Q** [AG]; VR**SSA (SEQ ID NO: 199633); TG**RSG (SEQ ID NO: 199585); R*KDS*A (SEQ ID NO: 199634); T*T*RSG (SEQ ID NO: 199516); T*TNR*G (SEQ ID NO: 199587); T*TSR*G (SEQ ID NO: 199511); G**SIRS (SEQ ID NO: 199635); GQSS**R (SEQ ID NO: 199636); M*KP*RD (SEQ ID NO: 199637); NDA**KK (SEQ ID NO: 199592); NK*DR*G (SEQ ID NO: 199638); QRP*A*A (SEQ ID NO: 199639); SP**RGG (SEQ ID NO: 199640); V*N*SSA (SEQ ID NO: 199641); or polynucleotides encoding the same, where “*” represents any amino acid and square brackets denote a list of amino acids that may occur at a position, wherein a viral particle having a capsid comprising the motif has increased binding to a liver cell relative to a control viral particle;
wherein the library comprises an amino acid sequence motif selected from the group consisting of:
[NDGILST]K* [RNGHKPSTV] * [ANDGKFSY] [ADQST];
[RQGKMFPS] [RNGHPST] [RQGKPST] ** [ARQGMPSTV] [AEGS];
[MFTYV]K** [ANST] [AQSTY]G;
[NQGKMFSYV] [RQGLKS] * [ANDQKPS] [ARNQGMSTV] *G;
[RDQEK] [ARGLMST] * [ANGKPT] * [RNKMS] [AELM];
[{circumflex over ( )}ARDCEHFPWV]K [ANDQMPST] ** [RQGKMT] [NDEG];
[{circumflex over ( )}ACGHILPW] [RNDQGLKS] [{circumflex over ( )}DCELKFWYV] [{circumflex over ( )}RNCEILMFWY] **[RNDEGKFPS];
[NKMSTW] [ARKSTV] [NQGPS] [AQGKSV] **A;
[RNQGKTYV] * [ANQGMPST] [ANQGKST] * [AQGKMS] [AEGS];
[NQGIKFSTY]K[NDQHPS] *[ARNGKT] *[ADEPS];
[NMFTYV] [KPS] * [AQGKPTV] * [AQGKS] [DEGS];
[{circumflex over ( )}ADCEHILPW] [ARNQGKFPT] ** [ARNQKMSTY] [ARNQGMS] [ADEGPS];
[NQIKFY] [ADQLK] [ANGHM] **[ARQK] [NDGK];
[ARNDQGSTV] ** [RNQGKP] [RQEGKMT] [NEGKFS] [ARGK];
[NQGMT]K* [AQGPSTV] [AGMST] * [ANGS]; [DQKS] [QKMST] **[AGST]K[DEK];
[NQWV]K[GST] **SG; K** [ANQS] [ANQT] [ADGK] [ARDEG];
K**[NQSTY]S[AQGKT] [EGPS]; [RNQGT] *[AGST] [QGKT] [RGKT] *G;
[RNQGMST] [RNQGKPSV] [ANGPST] * [ARQGIKST] * [AGS];
[RNQGKTV] [RNQGKPS] * [ANQGSTV] [NGKMST] * [AGPS];
[QGKMT] [GFP]K* [NQEGTY] * [AQGY]; [NT] [AD] *K[RS] * [LP];
[NQMFTV] *K* [AQGMS] [AQGKTV] [EG];
[RGIKF] * [ARNQGT] * [AKMT] [ARGKS] [DEG];
[QMFT] [RNQGMPS] [RKP] [ANGST] **G; [NGMFT] [NGKS]K[DQT] **[GSW];
[GKFTY] *[AKPT] *[RNQST] [AGKST] [GS]; [QFS]K[GT] **[ST]A;
T [RNS] [ARGK] ** [RQGT] [EG]; T*N*SKG (SEQ ID NO: 199642);
[GSTYV] *K[QT] [NGS] * [GS]; [KMFPSY] [LK] *S* [ANQIST]G; K[KS] [DST] *S*G;
[RNQMPTV] *[GKT]S[ARQKS] *[AGS]; G*K*TAA (SEQ ID NO: 199643);
K* [ANS] [GS] [GT] * [ADP]; [RQGKP] * [GKP] [NDPT] [AQMS] *A;
[MFT] *K[APT] *[RQ] [ADS]; M*SKS*A (SEQ ID NO: 199596);
TK[NMP] **[ANQ]A; [NQGS]K**G[QGF]G; [NQF] [QS]K*[AS] *G;
GK[GT] [QT] **G; [RGT] [DGP]K[NQS] **A; TGK**[AST]A (SEQ ID NO: 199644); K[DS] [RN] *G* [AG]; [GMPTV] *K[ASTV] * [QST]G;
[ST]K* [AQ] * [QS]A; K*A[TV] * [RK]D; [MF]KN** [QP]A; Q [RQY] [KP] [ST] **A;
[NT] *KS* [ST] [AP]; TG**MKG (SEQ ID NO: 199645);
[QT] [RG] *S* [KT] [AP]; [FV] *K*TSA (SEQ ID NO: 199646);
QK[GT] [NS] **A; T**KS[GS]G (SEQ ID NO: 200022); [NP]K*S*GG (SEQ ID NO: 199647); NK**G[ST]A (SEQ ID NO: 199648); [QG]KN**SA (SEQ ID NO: 199649); TKS**SN (SEQ ID NO: 199650); MKNT**A (SEQ ID NO: 199651); Q*K[GS] *[NV]G; Q**KSNA (SEQ ID NO: 199652); NN**SKG (SEQ ID NO: 199653); M*N*GNA (SEQ ID NO: 199654); KTQ*S*S (SEQ ID NO: 199655); T**SGTP (SEQ ID NO: 199656); RS*S*GG (SEQ ID NO: 199522);
MG*R*GA (SEQ ID NO: 199514); [QT] *K[NS] [ST] *G; Q*KP*QG (SEQ ID NO: 199657); KA**GDR (SEQ ID NO: 199658); V*N*SSA (SEQ ID NO: 199641);
K*TG*RE (SEQ ID NO: 199659); M*K*TSG (SEQ ID NO: 199660); T*K*SSA (SEQ ID NO: 199661); YQK*S*S (SEQ ID NO: 199662); MK*T*TA (SEQ ID NO: 199663); KPN*S*A (SEQ ID NO: 199621); TK**GMG (SEQ ID NO: 199664); MPK*S*S (SEQ ID NO: 199665); DL*KP*K (SEQ ID NO: 199666);
KGNT**A (SEQ ID NO: 199667); MK*G*TG (SEQ ID NO: 199668); N**STMA (SEQ ID NO: 199669); NK**SDK (SEQ ID NO: 199670); T*K*SNS (SEQ ID NO: 199671); T*KG*VG (SEQ ID NO: 199672); TKQ**SA (SEQ ID NO: 199673); and V*NKV*G (SEQ ID NO: 199606); or polynucleotides encoding the same, where “*” represents any amino acid, square brackets surrounding a list of amino acids not preceded by the symbol “{circumflex over ( )}” denote a list of amino acids that may occur at a position, and square brackets surrounding a list of amino acids preceded by the symbol “{circumflex over ( )}” denote a list of amino acids that may not occur at a position, wherein a viral particle having a capsid comprising the motif has increased binding to a liver cell relative to a control viral particle;
wherein the library comprises an amino acid sequence motif selected from the group consisting of: KQ**AKD (SEQ ID NO: 199674); NR**GGA (SEQ ID NO: 199675); KKD**RD (SEQ ID NO: 199676); QRNS**A (SEQ ID NO: 199677); NRGQ**A (SEQ ID NO: 199583); KKD**KD (SEQ ID NO: 199678); R*KDS*A (SEQ ID NO: 199634); RN**SGA (SEQ ID NO: 199679); RQ*PT*A (SEQ ID NO: 199515): or polynucleotides encoding the same, where “*” represents any amino acid and square brackets denote a list of amino acids that may occur at a position, wherein a viral particle having a capsid comprising the motif has increased binding to a brain endothelial cell relative to a control viral particle;
wherein the library comprises an amino acid sequence motif selected from the group consisting of: [QKMPT] [NKMPT] [ARGKS] [AQGT] ** [AG]; [TV]KPS**G (SEQ ID NO: 199680); [QT] [KS] *G [NKT] *G; [KMT] [RT] [GS] ** [NMT]G; [RQMT] [RQGK] [QPST] * [RGTV] *G; [GM]K[PS] ** [NT]G; KPT**MA (SEQ ID NO: 199681); [QGKT] * [GPT] [NQGT] [RKT] *G; [KT] [KS]SS** [AG]; [NGS] [AK] * [GKS] [NST] * [AP]; [GK] *T* [RT] [QS]G; [QKT] [GKF] ** [RGT] [GSY]G; [QKS] [RGKT] * [NT] [ANGT] *G; T**NRGG (SEQ ID NO: 199556); [NK] [RY] *T*[TV]G; Q*PTS*A (SEQ ID NO: 199682); [FS] [NG]K*[GS] *G; QR**STA (SEQ ID NO: 199683); [QMS]K*G*[NT]G; K*ST*NG (SEQ ID NO: 199684); QRSS**G (SEQ ID NO: 199685); [KV] [NK] *[GV] *S[AG]; N[RT] [AR] *[NT] *A; KN*GQ*G (SEQ ID NO: 199686); K*S*QSA (SEQ ID NO: 199687); [RN] [ST] [KS] *S* [GP]; QKN*A*A (SEQ ID NO: 199688); RP**MAG (SEQ ID NO: 199689); N**STMA (SEQ ID NO: 199669); N*K*GGG (SEQ ID NO: 199690); KTT**GG (SEQ ID NO: 199691); YKQ**GG (SEQ ID NO: 199692); N*K*SNP (SEQ ID NO: 199693); NKN*G*A (SEQ ID NO: 199694); S**KTGG (SEQ ID NO: 199695); GN*VK*G (SEQ ID NO: 199696); M*SKS*A (SEQ ID NO: 199596); MK**SAG (SEQ ID NO: 199697); N*K*SQG (SEQ ID NO: 199698); NRPS**P (SEQ ID NO: 199699); QKT**GG (SEQ ID NO: 199700); RS*Q*QS (SEQ ID NO: 199701); and T*RT*GG (SEQ ID NO: 199702); or polynucleotides encoding the same, where “*” represents any amino acid and square brackets denote a list of amino acids that may occur at a position, wherein a viral particle having a capsid comprising the motif has increased binding to a brain endothelial cell relative to a control viral particle;
wherein the library comprises an amino acid sequence motif selected from the group consisting of: QSRT**P (SEQ ID NO: 199580); MSRN**A (SEQ ID NO: 199591); KKD**RD (SEQ ID NO: 199676); NRGQ**A (SEQ ID NO: 199583); KKD**KD (SEQ ID NO: 199678); KKD*K*D (SEQ ID NO: 199703); NR**GGA (SEQ ID NO: 199675); and R*KDS*A (SEQ ID NO: 199634); or polynucleotides encoding the same, where “*” represents any amino acid and square brackets denote a list of amino acids that may occur at a position, wherein a viral particle having a capsid comprising the motif has increased binding to a brain endothelial cell relative to a control viral particle;
wherein the library an amino acid sequence motif selected from the group consisting of: NR**GGA (SEQ ID NO: 199675); [STY] [KP] * [QS] [GSV] *G; [GM] **[GT] [GK] [NF]G; QRPN**A (SEQ ID NO: 199704); [QS]K[GT] *S*G; Q*K*AQG (SEQ ID NO: 199705); Q* [GK] [NS] [KS] *G; [QY] [RK]P*[AT] *[AP]; [QM]K*G*TG (SEQ ID NO: 199706); TK*N*QG (SEQ ID NO: 199707); K*ST*SG (SEQ ID NO: 199708); KN*G*SA (SEQ ID NO: 199570); KN*GQ*G (SEQ ID NO: 199686); MK**SQG (SEQ ID NO: 199709); TGT*R*G (SEQ ID NO: 199710); GK*ST*A (SEQ ID NO: 199711); MK*GS*G (SEQ ID NO: 199712); MSK**AG (SEQ ID NO: 199713); K*PTT*G (SEQ ID NO: 199714); KP*T*GG (SEQ ID NO: 199619); MP**SGS (SEQ ID NO: 199715); Q*K*SNG (SEQ ID NO: 199716); QKY*T*G (SEQ ID NO: 199717); R*PS*QG (SEQ ID NO: 199718); T**PTAG (SEQ ID NO: 199719); and TGKS**A (SEQ ID NO: 199622); or polynucleotides encoding the same, where “*” represents any amino acid and square brackets denote a list of amino acids that may occur at a position, wherein a viral particle having a capsid comprising the motif has increased transduction efficiency for a brain endothelial cell relative to a control viral particle;
wherein the library comprises an amino acid sequence motif selected from the group consisting of: N**SRQG (SEQ ID NO: 199528); SP**RGG (SEQ ID NO: 199640); NQ**RSA (SEQ ID NO: 199720); QKY*T*G (SEQ ID NO: 199717); S*QQR*G (SEQ ID NO: 199721); MRG**MG (SEQ ID NO: 199505); NR**GGA (SEQ ID NO: 199675); NRGQ**A (SEQ ID NO: 199583); T**NRGG (SEQ ID NO: 199556); T*S*RMG (SEQ ID NO: 199532); T*TNR*G (SEQ ID NO: 199587); and TAN*R*G (SEQ ID NO: 199586); or polynucleotides encoding the same, where “*” represents any amino acid and square brackets denote a list of amino acids that may occur at a position, wherein a viral particle having a capsid comprising the motif has increased binding to a brain endothelial cell relative to a control viral particle;
wherein the library comprises an amino acid sequence motif selected from the group consisting of: [QKMFT] [RNQP] [RQKPS] [ARDG] **G;
[RQGMSTY] [ARNKP] [RNGKPST] **[RNQGKMST] [AEG];
[QGF] [GPT] [RK] * [NMS] *G; [RK] [NQ] [PT] ** [AT]G;
[RMT] [RQGT] [NPST] * [RQV] *G; [KMST] * [NQGT] [RQGS] [RQT] *G;
[RNY] [RKP]Q** [QGT] [AG]; [NQKT] [RKP] ** [NGS] [NQGTV]A;
[RKMST] [NGKPS] * [ARQS] * [ANQGTY] [AS]; [RKMP] [NKS] * [ANQS] * [AGSV]G;
[RGMFT] [NK] * [AGPV] [NGKTV] *G; [RKMTY] * [RKPST] [AGST] [GST] * [GPS];
SK*GN*A (SEQ ID NO: 199722); KP[AP] **G[AG]; [NST] [RK] *T* [NGV]G;
[RNT] * [GKT] * [ARGK] [QMST]G; [GK] [NP] [KS] * [NS] * [AS]; QK*GT*G (SEQ ID NO: 199555); [RQK] ** [ANT] [RT] [GT]G; [RK] [NF] ** [GTV]SG;
[GK] [KP] *[SV]S* [NP]; TG*NK*A (SEQ ID NO: 199723);
[NT] [RT] [PS] [KS] ** [AP]; QKY*T*G (SEQ ID NO: 199717); RS**TQS (SEQ ID NO: 199724); [RN] *[NT] [RS] *GG; KTQ**AS (SEQ ID NO: 199725);
RS**GGG (SEQ ID NO: 199726); KPP*T*G (SEQ ID NO: 199727);
[KY] * [QP]T* [GT]G; S*TT*NG (SEQ ID NO: 199728); KSPT**A (SEQ ID NO: 199729); SRTT**G (SEQ ID NO: 199730); [GY]K[QT] [QT] **G; Q**KSNA (SEQ ID NO: 199652); K*NST*A (SEQ ID NO: 199731); TRS*T*G (SEQ ID NO: 199732); K*S*SGA (SEQ ID NO: 199733); N**SRQG (SEQ ID NO: 199528); VRP*T*G (SEQ ID NO: 199734); Y*T*SKG (SEQ ID NO: 199735);
TR*VS*G (SEQ ID NO: 199736); TG**RSG (SEQ ID NO: 199585); K*P*SGG (SEQ ID NO: 199737); KTS**GG (SEQ ID NO: 199738); N**GQKG (SEQ ID NO: 199739); N*GNR*A (SEQ ID NO: 199740); QR*NS*A (SEQ ID NO: 199551); QRP*S*A (SEQ ID NO: 199741); R*QN*TG (SEQ ID NO: 199742);
RP*T*AP (SEQ ID NO: 199743); SRTT*NG (SEQ ID NO: 199576); and
TKSS**A (SEQ ID NO: 199630); or polynucleotides encoding the same, where “*” represents any amino acid and square brackets denote a list of amino acids that may occur at a position, wherein a viral particle having a capsid comprising the motif has increased transduction efficiency for a brain endothelial cell relative to a control viral particle;
wherein the library comprises an amino acid sequence motif selected from the group consisting of: [{circumflex over ( )}ADCEGHILWY] * [{circumflex over ( )}DCEGHILFWY] [ARNGKMPST] [ARNQGISTV] *G;
[{circumflex over ( )}ADCEHILMWY] [{circumflex over ( )}DCEHILFPWY] [{circumflex over ( )}RCEHILMFW] *[{circumflex over ( )}NDCEHLFPWY] *G;
[{circumflex over ( )}ADCEHILMW] [{circumflex over ( )}CEGHIFWYV] [{circumflex over ( )}CEHILFPW] [{circumflex over ( )}CEHILKMFWY] **G;
[RNDQKMPV] [ARNQMPST] ** [ARNQGKST] [ARNDQGKTV] [ARDIKPS];
[{circumflex over ( )}ARDCEHILW] [ARQGKPST] ** [ARNQKMSTV] [ANQGKMTYV]G;
[{circumflex over ( )}ACEHILMFSW] [{circumflex over ( )}CEHIKFWYV] *[{circumflex over ( )}DCQEHLFWY] [{circumflex over ( )}DCEHLFTWY] *[AEGLKP];
[RQKMSTV] ** [ARNQKPSTV] [ARNQGMSTV] [ARNQGSTV]G;
[{circumflex over ( )}RDCEHLPW] [{circumflex over ( )}CEHILMPSWV] [{circumflex over ( )}ANCEILMFWV] * [{circumflex over ( )}DCQILMFWV] * [NDQEGMPSY];
[RNQGKMS] [RQKST] [{circumflex over ( )}RDCEHILFWY] * [ARNMSTV] * [APS];
[{circumflex over ( )}ADCEHLFPW] * [ARNQGPST] [RQGKSTY] * [ANGKMSTV]G;
[{circumflex over ( )}ADCEHIK] [{circumflex over ( )}CQEHILFWY] [ARNQGKMPS] ** [ANQGKMSV]G;
[{circumflex over ( )}ADCEHPTWV] [{circumflex over ( )}ARCEIFWYV] [{circumflex over ( )}CILFTWY] ** [ARQGKPSTV] [ANDQEGKMS];
[RNQGSTV] **[RNGKSTV] [{circumflex over ( )}ADCHLMFPWY] [{circumflex over ( )}CHILKPWYV] [AGKPSV];
[RNGKFTYV] * [ARNQGPST] * [ARNQKPSTV] [ADQGKMSTV]G;
[ANQMFSTV] *K* [AQGST] [ANQGMST]G;
[{circumflex over ( )}ADCEHILW] * [{circumflex over ( )}ACEHILFWYV] [ANQGKPSTV] * [{circumflex over ( )}DCEHILKFWY] [ANDGPSY];
[{circumflex over ( )}ADCEHITW] [{circumflex over ( )}DCEGHIMFWY] * [ANQGMPSTV] * [{circumflex over ( )}RDCEHLPTWY]G;
[RNQILKFSV] [QGKPST]T** [ARQGKMST] [ADEGS];
[{circumflex over ( )}ACHILKW] [{circumflex over ( )}CEHILMFPWY] [{circumflex over ( )}NDCELFWYV] [{circumflex over ( )}RNCEILMFWY] ** [{circumflex over ( )}CQHILKMPTY];
[RNQGKMSY] [{circumflex over ( )}RDCGHILMWY] ** [ARGKMSTV] [{circumflex over ( )}NDCEHLPWYV] [DGPS];
[{circumflex over ( )}ARCEHILWY] [ARQGKST] *[{circumflex over ( )}CQEHILMFWY] [ARNGPST] *[NDGPS];
TK[ANQMST] ** [QKS] [NDS];
[NQGKMST] * [ARNQGKPS] [ARNQGPTV] [RNQHKMT] * [NGPS];
[NGFST]K** [ANGSTY] [ANGMPT]A; [RQMFS] [RKPT] ** [NQGT] [NQS] [NGS];
[{circumflex over ( )}ADCEHPTW] [RNQLKMPST] * [{circumflex over ( )}CEILKFWY] * [{circumflex over ( )}CEHILPSWY] [ANDQEKPS];
[QT] * [QT]R*QA; [RNGT] * [RNGKST] [ARNQGT] [RNQGKMT] * [AG];
[DQEMPST] [ARGK] *[ARNQGKS] *[ADQGKSY] [ADLMPT];
[NGIKFTV] * [ARNGKTY] * [NQKMSTV] [ARNIKSV] [ADEPS];
[RNQKMFST] [RDQKS] [RNQPST] *[AGS] *[AS];
[RQGKS] [QKST] [RNQST] ** [NT] [GPS];
K** [ANGSTY] [QGMST] [ANGKMT] [ADEGP];
[RKM] [RNQGPS] * [ANQST] [NQST] * [GS]; [RQGIKT] [PS] [RKPS] * [ANGMT] *G;
[RQKM] * [NPS] * [AQGT] [ANQGST] [APS];
[ADK] ** [NGPST] [AEGMST] [ANQGKT] [ARS]; [QKMPTV] * [NKPS] [QGKPT]S*A;
[RNQGST] * [RNQGKSV] * [RNQGK] [AGKTV]G; [NQGKT] [RNK] * [ANGST] [ANGMT] *A;
[RNQGKMY] [RNQGS] * [NQGKS] * [AQGST] [AG]; [NK] **G [QT] [KS]G;
[RKMTY] [RP] [RNGKPS] * [ANQST] * [GPST];
[QKMFPYV] [RNGKPST] [RNGPST] [ARDQGKST] ** [GPS];
[RNQGKWV] [ANQKPSTV] [ARNQGKST] [AQGKST] ** [AP]; TK* [GSTV] * [QGV]G;
T[RGS] [RGKT] **[RNST] [EGP]; [RGV]P[RNK] *[QST] *A;
[RKMV] * [ANPST]S [GKST] * [DGPS];
[NQMSTV] [RNQGHK] ** [ARGIKMST] [ARQKSV] [ADE]; [NQK] * [NKT] *S [NV]G;
[RNQFT] [RQK] [QGKST]N** [APS]; [NT] [GK] [NKMS] ** [ANQT]A;
[RQK] * [ANQGPST] [NGS] [ANGKPT] * [AGP]; [TYV] * [RK] [QGT]S* [GPS];
[NK] [RNP] [PT] [NS] ** [GP]; K* [NG] [AY] *KE; [NQ]R[NQGT] ** [NQT]A;
MKN* [GS] *G (SEQ ID NO: 199744); [QGKM] * [GS] * [KS] [NG] [AG];
[RNGMTYV] [RGKS] * [AQKPS] [NGS] *A; [QMTYV] [GK] * [NGKS] *TG;
[QKM] [RKMS] [NDP] [GSTV] **A; [NQSY]K* [QS] [ANQSV] *G; [QMT]RP** [AMS]A;
K*T [GI] * [RK] [DE]; [RQP] * [KPT] [DQGS] [AS] *A; TKP** [AQ]A (SEQ ID NO: 199745); T [RK] ** [NGL] [NMS] [AG]; K**Q[AS] [GK] [DS]; RQ* [NP]T*A (SEQ ID NO: 199746); [KS] [GY] *T* [TV]G; K* [QT] [GT] [GS] * [AS]; RT*T*SA (SEQ ID NO: 199747); K*A[NV] *[RS] [DG]; [NK] **Q[AR]S[AS];
[QG] [RP] [KP]N**A; [RT] [GS] ** [RN] [ST]G; MRPN**G (SEQ ID NO: 199748); G*KSV*G (SEQ ID NO: 199601); NK*T*SA (SEQ ID NO: 199749);
[NF] * [NK] * [NG]T [AS]; [GK] [KP] [NQT] * [GS] *A; MRT**SP (SEQ ID NO: 199750); [NM]K*QT* [GS]; GN**KNG (SEQ ID NO: 199751);
[NT] [GT] [RK] *N*A; K*ASS*A (SEQ ID NO: 199571); RT*GT*G (SEQ ID NO: 199752); [RQS] [AR] [PT] ** [NV] [GS]; RPT*S*[GS](SEQ ID NO: 199753);
K**GKSA (SEQ ID NO: 199754); [GV]KP**NA (SEQ ID NO: 199755);
TK*T* [KS] [AD]; TGK*G*A (SEQ ID NO: 199756); KP*GT*G (SEQ ID NO: 199757); RP*QQ*A (SEQ ID NO: 199758); KPNN**P (SEQ ID NO: 199759);
TGK**SA (SEQ ID NO: 199620); G**QKSG (SEQ ID NO: 199760); TG**KTA (SEQ ID NO: 199761); TN**RQG (SEQ ID NO: 199762); TG*K*SG (SEQ ID NO: 199763); I*AR*KE (SEQ ID NO: 199764); N*K*NNG (SEQ ID NO: 199765); R*S*STP (SEQ ID NO: 199506); KGNN**G (SEQ ID NO: 199567);
TK*N*QG (SEQ ID NO: 199707); G**QKGG (SEQ ID NO: 199766); K*AT*KD (SEQ ID NO: 199767); K*NQS*G (SEQ ID NO: 199768); KPS*N*A (SEQ ID NO: 199627); R*S*NVA (SEQ ID NO: 199769); RP*GT*A (SEQ ID NO: 199770); SRTT*NG (SEQ ID NO: 199576); TKQ**SA (SEQ ID NO: 199673); and TS**RTP (SEQ ID NO: 199771); or polynucleotides encoding the same, where “*” represents any amino acid, square brackets surrounding a list of amino acids not preceded by the symbol “{circumflex over ( )}” denote a list of amino acids that may occur at a position, and square brackets surrounding a list of amino acids preceded by the symbol “{circumflex over ( )}” denote a list of amino acids that may not occur at a position, wherein a viral particle having a capsid comprising the motif has increased biodistribution to liver relative to a control viral particle;
wherein the library comprises an amino acid sequence motif selected from the group consisting of:
RQSA**T (SEQ ID NO: 199772); RAHS**A (SEQ ID NO: 199773); DG*K*KL (SEQ ID NO: 199774); NR*A*DK (SEQ ID NO: 199775); G*N*ANR (SEQ ID NO: 199776); RQ**NST (SEQ ID NO: 199777); [RKT] [STV] [RQE] **R[ADE];
T*GG*RN (SEQ ID NO: 199778); Q*G*VRG (SEQ ID NO: 199779); MDK**QR (SEQ ID NO: 199780); NGG**GR (SEQ ID NO: 199781); V*RQ*AG (SEQ ID NO: 199782); L*REG*R (SEQ ID NO: 199783); QAG**RG (SEQ ID NO: 199784); QR*VV*A (SEQ ID NO: 199785); RE**ARG (SEQ ID NO: 199786);
RQMA**A (SEQ ID NO: 199787); S**REIR (SEQ ID NO: 199788); TK*R*DT (SEQ ID NO: 199789); V*R*SAG (SEQ ID NO: 199790); V*RS*GG (SEQ ID NO: 199791); and VQR* S*G (SEQ ID NO: 199792); or polynucleotides encoding the same, where “*” represents any amino acid and square brackets denote a list of amino acids that may occur at a position, wherein a viral particle having a capsid comprising the motif has increased transduction efficiency for a liver cell relative to a control viral particle;
wherein the library comprises an amino acid sequence motif selected from the group consisting of:
[RNGPS] * [GKSTY] [RNGKST] * [ANGMSTV]A;
[RNGKST] [NQGKP] * [NQGKPS] [NQKMSTV] *A; K** [AS] [AS] [AK] [EPS];
[RNQGKPSTV] [ARNGKPSTV] [ANDQGPSTY] [NQGKPST] ** [AMPSV];
[RQGKPST] [RQLKPT] [NDQST] * [ANQGSV] * [AGSV];
[RGKMST] [NKPST] ** [AQGKSTV] [ANDQG] [RDGPS];
[RKMPST] [ARGKPST] [ANQPSTYV] ** [ARNGKMST] [ADMPS];
[NDGPT]K* [NQGKPT] * [NQG]A; [KP] [RNGPT] * [QGST] [ANQT] * [GPS];
[QGPS] [QK] ** [ANST] [GMST]A; [NGPT] [NQGK] [NKV] ** [ANGST]A;
[NPST] * [NK] [AQKT] * [QS] [PS]; [RNGK] * [NQST] [ANQGKST] [ARNGPT] *A;
[RNQPST] [QGK] *S* [ANQGKS] [GP]; K[NPT] * [ANGS] * [QTV]A;
[RQPT] [NDGKT] [KS] [AGST] **A; [RNQK] [PST] [NQKT] ** [NQT] [APS];
[KP] [RQP] *T [GT] *A; [RKP] [QS] [NGKPS] * [GT] *A; K* [NS] [AQGT] * [QGS]A;
[RN] [ANSV] [NGK] ** [QMV]G; [NK] [KST] ** [NGP] [AQGT]A;
[NGK] * [QKT] * [NQGP] [QGMTV] [AGS]; [QPST]K* [NGPS] [AMST] * [AG];
[KT] [RT] *SG* [PV]; KQ[GT] [QT] **A; [NKMT] * [RNQPS] [NGK] [ARGT] * [GMPV];
K*N* [NG] [NGV]A; R[PS] * [PS]G*A; [GST] [QGS]K*N*A;
[KS] * [NT] * [GS] [IS] [AP]; NKPA**S (SEQ ID NO: 199793);
[GKPS] [RKST] * [AQS] * [NS] [AGS]; [NK] ** [NPST] [GPT] [ANM]A;
[NQP] *K[PST] [ST] *A; [PT] *KG[AG] *A; SK[MT] **Q[AP]; NTR**SA (SEQ ID NO: 199503); PKS**SG (SEQ ID NO: 199794); TK*PS*S (SEQ ID NO: 199795); [NG] *K[ST] [QT] *[GP]; FGKQ**S (SEQ ID NO: 199796);
[NQ] [RKPSTV] [ARNKT] * [NGT] * [AGM]; [RK] * [NT] [NS] * [NS]P; K*N[QT]S*A (SEQ ID NO: 199797); [KMS] ** [GS] [AN] [NQT] [AG]; [NQ]K* [AT] [AG] *A;
KQ**AKD (SEQ ID NO: 199674); K*[PT]S*[AQG]A; [NMS] *K[PS] *[NG]G;
NAKS**G (SEQ ID NO: 199798); KQ**TQA (SEQ ID NO: 199799);
[NK] [ST] [NK] *[AT] *P; K*TQ*GA (SEQ ID NO: 199800); T**QSGF (SEQ ID NO: 199801); KTQ*T*G (SEQ ID NO: 199802); QK**GAP (SEQ ID NO: 199803); SK**NAA (SEQ ID NO: 199804); K*AT*KD (SEQ ID NO: 199767);
R*N*ANP (SEQ ID NO: 199805); GKQ*S*P (SEQ ID NO: 199806); PQKS**A (SEQ ID NO: 199807); N[GK] *[KT] *SA; SQ**TNP (SEQ ID NO: 199808);
PR*Q*SP (SEQ ID NO: 199809); NG*R*TP (SEQ ID NO: 199810); TKM**QA (SEQ ID NO: 199811); NK*TN*S (SEQ ID NO: 199812); N*K*NNG (SEQ ID NO: 199765); PK*GN*A (SEQ ID NO: 199813); FQKA**G (SEQ ID NO: 199814); G*KT*QA (SEQ ID NO: 199815); K**TSQS (SEQ ID NO: 199816);
K*ASS*A (SEQ ID NO: 199571); MNQ*R*P (SEQ ID NO: 199817); RQ*A*TS (SEQ ID NO: 199818); SK**NQP (SEQ ID NO: 199819); and TKN**QS (SEQ ID NO: 199820); or polynucleotides encoding the same, where “*” represents any amino acid and square brackets denote a list of amino acids that may occur at a position, wherein a viral particle having a capsid comprising the motif has increased biodistribution to heart relative to a control viral particle;
wherein the library comprises an amino acid sequence motif selected from the group consisting of:
[GFTW] [AKM] [NQKPT] [QGKP] ** [AG]; [MT] [RGP] [RQP] [KS] **G;
[QMT] [RGP] [RQGP] * [QKMT] *G; [QG] * [AGP] [GT]K*G; [RF] [KP] ** [AQ] [NQ]G;
KT [AS] ** [GK] [AEP]; G**TKMG (SEQ ID NO: 199821);
[GK] * [PT] [QG] * [QS]G; [GT] [NG] ** [RK]SG; [QT] * [RG]S [KT] *G;
[QK] * [GP] * [KST] [GSV]G; [RM]SS [KT] ** [AS]; [RM] [NQG]S* [GKV] *G;
[MT] *STK*G (SEQ ID NO: 200023); K[GT]S[QT] **G; K*P[NS] *GA (SEQ ID NO: 199822); K[MST] [PS] [GT] **A; K[DT] [AR]S** [AG]; [IY]KP** [KS] [ND];
R[NQ]S [AS] **G; M*SKS*A (SEQ ID NO: 199596); K*S [AN] * [AGS] [AS];
[QGF] [NKS] * [GPV] [NGK] *G; [RK] [DST] [RS] * [GS] * [AGP];
[KT] [GY] *[KT] *TG; R*SN*TG (SEQ ID NO: 199552); AKY*K*E (SEQ ID NO: 199823); [KT] [QG] [AT] **[ST]G; MR*NQ*G (SEQ ID NO: 199604); K*PT*TG (SEQ ID NO: 199824); NRPS**P (SEQ ID NO: 199699); KRPD**G (SEQ ID NO: 199825); R*SSV*G (SEQ ID NO: 199826); KSSS**G (SEQ ID NO: 199827); TK*S*YA (SEQ ID NO: 199828); FK*S*QG (SEQ ID NO: 199829);
K**NTTG (SEQ ID NO: 199830); FK*P*QG (SEQ ID NO: 199831); FKM**QG (SEQ ID NO: 199832); GK*VS*N (SEQ ID NO: 199833); K*SSV*G (SEQ ID NO: 199834); K*ST*NG (SEQ ID NO: 199684); KF**TSG (SEQ ID NO: 199835); KGSS**P (SEQ ID NO: 199836); N*K*GMG (SEQ ID NO: 199837);
and YKP*T*P (SEQ ID NO: 199838); or polynucleotides encoding the same, where “*” represents any amino acid and square brackets denote a list of amino acids that may occur at a position, wherein a viral particle having a capsid comprising the motif has increased biodistribution to spleen relative to a control viral particle;
wherein the library comprises an amino acid sequence motif selected from the group consisting of:
[NEGKMFTWY] [ARDKPST] [ARNQGST] [ANQKPST] ** [AGFS];
[ARQLKM] [ANGHIT] * [RQGHP] * [AGKST] [ARDKS];
[GKFTY] [GKT] **[ARGV] [AQFS]G;
[NGKT] **[NGKMPT] [LKPST] [NGHKMFT] [RDGSY];
[RNQKMT] [RNGIL]P [NDHKST] ** [ANGKPV];
[DEGKMFT] [GKMFP] [ARHMF] ** [NQGKST] [DGKP];
[RQGFYV] * [RGLKPS] [RNGS] * [ANDQPT] [RGKPY];
[RQKM] [RGT] * [NGP] [AQGPV] * [GMY];
[RQGIKMTYV] [RNDQGHPST] [{circumflex over ( )}DCEILMFWYV] * [{circumflex over ( )}DCEHLKFWY] * [ANGKFPS];
[RGKMSTV] *[ARNHMST] [NQKST] [ARGKTV] *[ARG]; K*PG*QG (SEQ ID NO: 199839); [QGFT] [ANK] * [APTV] [ARNGKP] * [GV]; [TY]KP*T* [PY];
[QGTY] [RK]P** [AGMS] [ANG]; [GLMTY]K* [HPS] * [NFSY] [AQG];
[NKT] [RGY] * [KT] * [TV]G; [RM] [HP] [KP] ** [HP] [AM];
[RKMTY] * [GPT] * [ARNST] [QGKS]G; Q* [RP] [QG] [KT] * [GP]; S*NAH*R (SEQ ID NO: 199840); R**VRDV (SEQ ID NO: 199841); KM**PKD (SEQ ID NO: 199590); RP**[QG] [NG]G; SP**RGG (SEQ ID NO: 199640);
[MST] [HKY] [GP] [AQ] ** [KY]; [QFV] [QP] [RNG]H** [KV];
[RY]P*[KS]S*[AGS]; FK*[PS] *QG (SEQ ID NO: 199842); MGS*K*G (SEQ ID NO: 199843); [NK] * [RS] * [TV] [TY] [GM]; G*TQ*SG (SEQ ID NO: 199844);
TR*VS*G (SEQ ID NO: 199736); YKPP**G (SEQ ID NO: 199845); QR*S*TG (SEQ ID NO: 199525); SK**YGA (SEQ ID NO: 199846); TK*VS*N (SEQ ID NO: 199847); QK*PS*A (SEQ ID NO: 199848); GK*ST*A (SEQ ID NO: 199711); QKS*S*G (SEQ ID NO: 199849); K*TI*KD (SEQ ID NO: 199850);
GK*PS*A (SEQ ID NO: 199851); AKY*K*E (SEQ ID NO: 199823); FK*T*MS (SEQ ID NO: 199852); GK*VS*N (SEQ ID NO: 199833); K*MQ*QG (SEQ ID NO: 199853); Q*KPH*N (SEQ ID NO: 199854); QKT**GG (SEQ ID NO: 199700); QPRG**G (SEQ ID NO: 199855); R**SVAG (SEQ ID NO: 199856);
R*Q*APF (SEQ ID NO: 199857); and SK**NQP (SEQ ID NO: 199819); or polynucleotides encoding the same, where “*” represents any amino acid, square brackets surrounding a list of amino acids not preceded by the symbol “{circumflex over ( )}” denote a list of amino acids that may occur at a position, and square brackets surrounding a list of amino acids preceded by the symbol “{circumflex over ( )}” denote a list of amino acids that may not occur at a position, wherein a viral particle having a capsid comprising the motif has increased biodistribution to kidney relative to a control viral particle;
wherein with the library comprises an amino acid sequence motif selected from the group consisting of: YMNN**K (SEQ ID NO: 199858); I*RS*TG (SEQ ID NO: 199859); NGG**GR (SEQ ID NO: 199781); and RQMA**A (SEQ ID NO: 199787): or polynucleotides encoding the same, where “*” represents any amino acid and square brackets denote a list of amino acids that may occur at a position, wherein a viral particle having a capsid comprising the motif is capable of transducing kidney cells in vivo.
wherein the library comprises an amino acid sequence motif selected from the group consisting of:
GK** [ST] [NMT] [AP]; [NK] * [NS] [KT] [NS] *A; [NGP] [QKS] [KT] * [NGS] * [AG];
K*N[AN] * [NQG] [AP]; [NQKPS] [NQKT] [AQGKST] [AQGST] ** [AGS];
[KP] [KPST] ** [ANK] [ANDG] [ADPS]; [NKV] [NG] * [GK] * [KST] [AG];
[GP] [RNK] [NKPT] ** [GS] [AM]; K*TS* [AS] [AV];
[NGPST] [GK] *[NQGKS] [NKT] *A; PR*Q*SP (SEQ ID NO: 199809);
[NP] [RKS] [NK] * [GT] * [APV]; [NG] [QK] [KT]N**A;
[RPST] [KT] [NMS] ** [AQT] [PS]; [NT] *KS* [ST] [AP];
[KM] [NPT] **G[QG] [ARS]; K*N* [GS] [NI]A;
[RNPS] [ARNK] [ANG] [QGKS] ** [AGP]; K[LKPT] [ND] * [AGS] *A;
KT [NQ] ** [AQGMS] [AS]; K[NQT] * [GPS] [AQGV] * [APV]; [PS] *K[AQ] *QS;
[NP] *KS[ST] *A; KQ[GT] *[TV] *A; K*TS*QA (SEQ ID NO: 199860);
[KT] * [NKP] [NG] [AG] * [AMP]; P*KG*GV (SEQ ID NO: 199861);
[NP] [RG] * [QS] [QK] *P; KP [QS] [NT] ** [AM]; K**PGMA (SEQ ID NO: 199862); N*K*NNG (SEQ ID NO: 199765); RPNN**P (SEQ ID NO: 199863);
K*T*QQA (SEQ ID NO: 199864); [PS]K[PT] **[QG] [AS]; PK*PS*A (SEQ ID NO: 199865); KTV**KD (SEQ ID NO: 199866); KA*TN*A (SEQ ID NO: 199867); KN*A*QA (SEQ ID NO: 199868); K*QTG*A (SEQ ID NO: 199869);
KTNG**P (SEQ ID NO: 199870); K*T*NTS (SEQ ID NO: 199871); KTN*A*P (SEQ ID NO: 199872); KST**TA (SEQ ID NO: 199873); DK*K*GA (SEQ ID NO: 199874); KPNN**P (SEQ ID NO: 199759); KTQ*S*S (SEQ ID NO: 199655); N*QKT*G (SEQ ID NO: 199875); K**TGNA (SEQ ID NO: 199876);
K*N*NVA (SEQ ID NO: 199877); KP*TN*S (SEQ ID NO: 199878); KPA**GA (SEQ ID NO: 199879); P*KG*SA (SEQ ID NO: 199880); QK**GAP (SEQ ID NO: 199803); SK*S*QP (SEQ ID NO: 199881); or polynucleotides encoding the same, where “*” represents any amino acid and square brackets denote a list of amino acids that may occur at a position, wherein a viral particle having a capsid comprising the motif has increased biodistribution to serum relative to a control viral particle;
wherein the library comprises an amino acid sequence motif selected from the group consisting of:
[RQKP] [RQPT] ** [ANGT] [ANGS] [AS];
[RNQKP] [RGST] [RNQKPV] ** [ARNGKMST] [RDGMPS]; K* [NQT] * [QGS] [NQIM]A;
[EGKMPST] [RGKPST] [ANQPSTYV] **L[ANGST] [AKPS];
[RNQGKPW] [ARNQGPST] [ANDQGKS] [NQGKT] ** [AKMPS];
[NGT] * [KS] [NGKS] [ANGMT] *A;
[RNGHKMP] * [NQGPSTYV] [ARNQGK] * [ANQGKS] [ARDG];
[NKT] *[NQPS] [NGK] [ARGT] *L[GMP]; [NGPS] *[NQK] [AQKT] *[NQST] [GPS];
[NQGMPSV] [KS] [ANKSTY] [ANQGT] ** [AP];
[RGKMPSV] [QKPST] [NDQKST] * [ANQGSV] *A; [KMPT] [RPT] [NK] * [GS] * [GPSV];
[QGPSTV]K* [NQGPSV] [ANMST] * [AGPS]; [QK] * [NG] [NS] * [NGV] [GP];
[RGTV] ** [NQS] [QGTY] [NMT] [AKP]; [NPS] *K[GS] * [ST]A;
K** [QG]A [QS] [AS]; [NQPT] [KV] [NQKT] * [AGS] * [GMS];
[RNGKT] [QGPST] * [NQGKS] [ANQGKTV] * [AGV]; [QGT] [GT]K** [AT]A;
[NDKS] * [RKT] * [NGMS] [NPST] [KPS]; [NK] [AGT] * [GKS] [AKS] *P;
[GK] * [QHK] * [NP] [LTV] [AQ]; [QKP] * [ANK] [QST]S*A;
[NV] [RS] [AKP] * [NT] *A; [NST]K[MPT] ** [QG] [AP];
[NQKST] [RNK] [ANDQST]S**A; T**SSNR (SEQ ID NO: 199882);
[KP] [ARQ] *T [NGT] *A; [NQG] [QK] * [KST] [ANGS] * [AM]; [SV] [RK]TS** [GP];
K**GTNA (SEQ ID NO: 199883); NK[NQ] *[AG] *A; K*[PT]S*[QGS] [AV];
[KTW] [NKT] [QGS] **Q[ANKS]; [RNKP] [RNGT] * [QGKPS] * [GST] [APS]; PKS**SG (SEQ ID NO: 199794); RDKS**A (SEQ ID NO: 199612);
[RY] * [ST] [KS] * [ST] [AP]; [GF] *K[QT]T* [PS]; [RN] * [AP] [GK]S* [AG];
RNGS**G (SEQ ID NO: 199884); KT [NQG] * [AS] * [GPS]; K*NSS* [PT](SEQ ID NO: 199885); Q*GSK*G (SEQ ID NO: 199886); KVS*T*A (SEQ ID NO: 199887); NSK*T*P (SEQ ID NO: 199888); [NGP]K* [NGPST] * [ANQG]A;
K[NT] * [AG] *QA; [GKP] [QKT] ** [ANST] [NGMT] [AP]; QK**GAP (SEQ ID NO: 199803); FQK*A*G (SEQ ID NO: 199889); K*QTG*A (SEQ ID NO: 199869);
[KS] [QK] **[QT]Q [AP]; KQTQ**A (SEQ ID NO: 199890);
[GP] *K[GT] *[QG] [AV]; [SV] *[RK] *SAG; MN**GQR (SEQ ID NO: 199891);
[NS]K*A*S[AG]; K**TGNA (SEQ ID NO: 199876); N*K*GQG (SEQ ID NO: 199892); TK*V*QG (SEQ ID NO: 199893); QK*TS*P (SEQ ID NO: 199894);
QK*S*[QS] [PS]; NKV**SA (SEQ ID NO: 199895); K*SGT*A (SEQ ID NO: 199896); PK*S*AG (SEQ ID NO: 199897); G*Q*TQG (SEQ ID NO: 199898);
K**TSQS (SEQ ID NO: 199816); K*TST*A (SEQ ID NO: 199899); KNGS**G (SEQ ID NO: 199900); KQG*T*A (SEQ ID NO: 199901); NVK**QG (SEQ ID NO: 199902); PR*QQ*P (SEQ ID NO: 199903); SN**KSA (SEQ ID NO: 199904); and T*KS* T P (SEQ ID NO: 199905); or polynucleotides encoding the same, where “*” represents any amino acid and square brackets denote a list of amino acids that may occur at a position, wherein a viral particle having a capsid comprising the motif has increased biodistribution to brain relative to a control viral particle.
wherein the library comprises an amino acid sequence motif selected from the group consisting of:
[NPT]K[PY] [GP] **A; KT**PQA (SEQ ID NO: 199906); KT**AKE (SEQ ID NO: 199907); [KPTY] [RQKT] [APSY] ** [AGKS] [ANE];
[RQK] [QPST] [KS] [MST] **G; K* [AGS] [NS] [AST] * [AP];
[RK] [GST] [AS] [GST] ** [APS]; Q*GSK*G (SEQ ID NO: 199886);
[RKMT] [RQGKS] [PS] * [QKSTV] *G; [RKY] [QKT] [PST] * [STV] * [AP];
[NK] [RMS]P[GST] **[AP]; [MT]PK*[AT] *G; K*TTG*G (SEQ ID NO: 199908);
[TV]KP[GS] **G; PK**NGA (SEQ ID NO: 199909); PK*PS*A (SEQ ID NO: 199865); TPR*G*G (SEQ ID NO: 199910); KTQ**QA (SEQ ID NO: 199911);
QPK*G*G (SEQ ID NO: 199912); RNS**NG (SEQ ID NO: 199913); K**NTTG (SEQ ID NO: 199830); K*ST*[NS]G (SEQ ID NO: 199914); YKPP**G (SEQ ID NO: 199845); K*SSV*G (SEQ ID NO: 199834);
[RNQ] *[GKS] *[GK] [MTV]G; KQ*SV*A (SEQ ID NO: 199915); PR*Q*SP (SEQ ID NO: 199809); R*SN* [NT] [AG]; K*PS*QA (SEQ ID NO: 199916);
FK*TA*G (SEQ ID NO: 199917); GK*PS*A (SEQ ID NO: 199851); K*GS*MS (SEQ ID NO: 199918); K*SN*GS (SEQ ID NO: 199919); FK**AQG (SEQ ID NO: 199920); GQ*RV*G (SEQ ID NO: 199510); K*ASG*A (SEQ ID NO: 199921); K*SN*AA (SEQ ID NO: 199922); KY*T*TG (SEQ ID NO: 199923);
P*R*NGA (SEQ ID NO: 199924); QPR*M*G (SEQ ID NO: 199925); RPQ**TG (SEQ ID NO: 199926); T**VNRG (SEQ ID NO: 199927); and TPRS**G (SEQ ID NO: 199928); or polynucleotides encoding the same, where “*” represents any amino acid and square brackets denote a list of amino acids that may occur at a position, wherein a viral particle having a capsid comprising the motif has increased biodistribution to lung relative to a control viral particle;
wherein the library comprises an amino acid sequence motif selected from the group consisting of:
[RNGKS] [KPTV] [NQGS] * [ANQST] *A; K** [NST] [QS] [AQK] [DS];
[NGMPSTW] [RNQGK] [QGKMSTV] ** [AQKST] [ARNDGKP];
[RGKP] [QKPT] ** [NQST] [NQGMT]A; [NMPS] * [NQKS] [AQGHK] * [QGS] [RIPSV];
[RNLPS] [RGHKS] * [AQGKPT] * [ANGS] [ARGP];
[RQGMS] [NDQK] **[NGKS] [NQGS] [ARQKPT];
[RNQGKPSW] [ARNGKPT] [ANQGST] [ANQGKST] ** [AGKMPS];
K[NQT] * [AGS] *Q[AS]; [RKT] [KT] [NQV] ** [ARQKT] [DPS];
[RNGKMPS] [RQST] [NGHKT] * [NQGTV] * [AKYV]; [GT] ** [QS] [SY] [NM] [RK];
[KFSY] * [ANHKP] [NQS] [AGST] * [RMST]; [NKP] [ARGK] [GHPS] ** [AG] [RMST];
[GP]K* [NS] * [AQ] [AG]; [RKP] ** [QT] [QGS] [NG]A;
[QGKP] * [NKS] [KPST] [AS] *A; [GK] * [NQHT] * [NGPV] [QLMTV] [AQS];
[GK] * [NKPS] [ANGTV] * [AQT] [AM]; K*TS* [AQ]A (SEQ ID NO: 199929);
N* [ST] [GK] [RN] *A; [GK]Q [QGT] [QGT] ** [AM]; K*NN*NP (SEQ ID NO: 199930); K[PT] [QS] ** [AQS]A; [QKP] [NST] [KT] ** [GT]A;
[KV] [QT] [QK] *S* [AS]; [RNQGKS] [AQGKPT] * [NGKST] [ANGKTV] * [AMSV];
KN*G*SA (SEQ ID NO: 199570); T**GPGR (SEQ ID NO: 199931); K*TG*KD (SEQ ID NO: 199932); K**G[AT] [NQ]A; [QT] [NQK]K[DT] **A;
[NK]K[ND] *G*A; N*QKT*G (SEQ ID NO: 199875); K[GT]N**[GT]A; GKN**SA (SEQ ID NO: 199933); K[ST] ** [AK] [ND] [DP]; PK* [NGP] [ANS] *A; TK*V*QG (SEQ ID NO: 199893); K*SGT*A (SEQ ID NO: 199896); N*K* [NS]N[GP];
[NG]KT*G* [AM]; [MP] [GK]T*S* [RG]; [NP] *KS* [GS]A; KP** [AG] [AG]S;
SK*S*QP (SEQ ID NO: 199881); S*T*GSP (SEQ ID NO: 199934); HQKP**L (SEQ ID NO: 199935); N*N*GTA (SEQ ID NO: 199936); SRTP**A (SEQ ID NO: 199937); PR*QQ*P (SEQ ID NO: 199903); P*KG*SA (SEQ ID NO: 199880); VK*NN*P (SEQ ID NO: 199938); K*N*SIA (SEQ ID NO: 199939);
KPT*P*S (SEQ ID NO: 199940); T*KS*TP (SEQ ID NO: 199905); N*KST*A (SEQ ID NO: 199941); R*TS*SP (SEQ ID NO: 199519); K*N*GNA (SEQ ID NO: 199942); KTN**GS (SEQ ID NO: 199943); N**GRTA (SEQ ID NO: 199944); NKPP**A (SEQ ID NO: 199945); SK**TNS (SEQ ID NO: 199946);
SK*V*TS (SEQ ID NO: 199947); and TK*QN*A (SEQ ID NO: 199948);
TKQ*S*S (SEQ ID NO: 199949); or polynucleotides encoding the same, where “*” represents any amino acid and square brackets denote a list of amino acids that may occur at a position, wherein a viral particle having a capsid comprising the motif has increased biodistribution to spinal cord relative to a control viral particle;
wherein the library comprises an amino acid sequence motif selected from the group consisting of: GAG**MR (SEQ ID NO: 199950); LQSN**R (SEQ ID NO: 199951); NN*TT*R (SEQ ID NO: 199952); NQ*Q*TK (SEQ ID NO: 199953); and RVG**DK (SEQ ID NO: 199954); Y*AG*SR (SEQ ID NO: 199955); or polynucleotides encoding the same, where “*” represents any amino acid and square brackets denote a list of amino acids that may occur at a position, wherein a viral particle having a capsid comprising the motif has increased biodistribution to kidney relative to a control viral particle;
wherein the library comprises an amino acid sequence motif selected from the group consisting of:
WNG**QK (SEQ ID NO: 199956); [DY] [KT] [FS] ** [QK] [GK];
[QSWY] [NIKM] [NGP] [NQH] ** [KY]; IKH*R*E (SEQ ID NO: 199957);
[IT] [LK] * [DH] * [KV] [RN]; [KF] * [KS] * [PT] [NY] [LM]; YKD**PR (SEQ ID NO: 199958); HN*N*GK (SEQ ID NO: 199959); KFK*E*Y (SEQ ID NO: 199960); NGQ**AR (SEQ ID NO: 199961); QI*H*AK (SEQ ID NO: 199962);
R**NGIQ (SEQ ID NO: 199963); REKP**M (SEQ ID NO: 199964); Y*H*MKG (SEQ ID NO: 199965); or polynucleotides encoding the same, where “*” represents any amino acid and square brackets denote a list of amino acids that may occur at a position, wherein a viral particle having a capsid comprising the motif has increased liver transduction efficiencies relative to a control viral particle; or
wherein the library comprises an amino acid sequence motif selected from the group consisting of:
[{circumflex over ( )}ADCEHILKW] [ARNQGKST] [ARNQGKPTV] [ARNQKPSTV] **[NGPS];
[RNQKSV] * [ANQGPST] * [ARNQKT] [ANQGKT] [EGPS];
[{circumflex over ( )}ANDCEHILFW] * [ANQGKPST] [ARDQGKPST] [ARNQGKSV] * [ADGS];
[NQGFST] * [NGKT] * [ARNQKST] [ANQGKSTV] [GP];
[NQGKMSTY] [RQGKPST] * [ARDQGKSTV] [{circumflex over ( )}ADCEHILFWY] *G;
[RNGKMPT] ** [AQGKST] [ARNQGSV] [AQGKMST] [EGPS];
[NQGKFST] [ARQGKPST] [ADQGKPST] *[ARNQIKST] *G;
[RNQGHKPTV] * [ARNQGMPST] [ARNQKST] * [ANQGKMS] [DEGPSV];
[{circumflex over ( )}ARDCEHILKW]K* [ANQGST] * [ANQIKMSTV] [DGPS];
[RNGKTV] [ANQGSV] ** [ARGKSTV] [AQGKMS]G;
[{circumflex over ( )}ADCQEHFWY] [ARNQGKMPS] [{circumflex over ( )}CEHILKFWYV] ** [ANQGKMSV] [NDGPS];
[RNQGMPSTV] [ARDQGKPST] [NQGKST] [ANGKPST] ** [APS];
[RNGKMST] [RGKST] [RNQMT] **[ARNQMST] [ADPS];
[RNQGMPSTV] *[AQGKST] [AQGKPSTV] *[NQGKSTV] [GPSV];
[NQST] * [QKT] * [GKT] [NQMS] [GP]; [RNQKSTY] [RKPT] [ANQGST] ** [ANQGT]G;
[RNQMTYV] [NQKP] [RNQGS]G**G; [RGKMT] ** [NT] [RNGKS] [ANGT]G;
[RNGT] * [ANGKT] [ARNKMST] [RNQGKS] *G;
[RQGKMPST] [NQKPST] ** [ARNKST] [{circumflex over ( )}RCQEHILFPW] [DGPS];
[RKS] [NQGPST] [ANQGKT] [ANQGT] ** [APS];
[RNMPSTY] [ARNQGKSV] * [ANQKST] * [ANGKSTV] [GPS];
[NQGKPSTV] [ARQGKST] * [AQGKPST] [ANKSTV] * [APS];
[RNQGKTY] [RNQGLPST] [ARNQKPST] * [ANQSTV] * [APS];
[NQGFST] [ANGSV] [RK] ** [NQSV] [GP]; K[NQGLKST] [NDQGMPT] [NQST] **G;
[NQGKMFPST] [RQGKPS] [RDQKPST] *G* [AM];
[RQGKMST] [QKP] [NDQGS] * [ANKST] * [ADEPS]; K* [QT] * [QG] [QMT]A;
[NKMST] [ANGKP] [NGKP] * [ARNMPST] *G; [RNQPST] [RNK] ** [ARNGS] [ANGSTV]A;
[QGS]K** [GT] [AMT] [APS]; [NQGMST] [NK] ** [AQGSV] [QKMFS] [RDGPS];
[RDKST] [NQKP] *[AGKS] *[AGSTV]A;
[NQGKSTV] [RNQGK] * [NQGKS] [ANQKST] * [GPS]; [QK] [NKSV] [NDGKT] [ST] **A;
[RKMT] ** [GPS] [AT] [ANGS]G; [RKM] * [NPST] [AGT]T* [GV];
[RKV] ** [NGT] [AGST] [NQG]A; [QKST] [QKT] * [NG]G* [DG];
[RQGKT] * [RNQGPST] [RQGST] * [QGMS]A; [KV] *N* [NS] [AISV]A;
[NQKPT] [RKP] * [AGST]G* [AP]; [RNQKS] [ANMPSV] [RNQK] *G*G;
[RNST] * [QKMST] [RGS] [ARST] * [AP]; [NKS] [KST] [NK] * [NG] * [AS];
[RNGT] * [RQGKST] [NKST] [RNMT] * [AG]; [RKT] [RQT] ** [GT] [NQG]A;
[RNIK] [RNQV] *[AGS] *[NQGT] [GS]; [RGKP] [NKT] [NQTV] **G[AS];
[RNQST] [RQK]S [ANQKS] **G; R[NST] * [ANQG] [ANTV] *G; [QK] [QT] **N[GS]A;
[QPT] [RGK] *N[AKS] *A; [QGT] [QGT]K** [AT]A; RP* [NG] [NT] *G;
[FT]K**NQ[NG]; [NGS] *[GKS] [RGKS] *[AGST]A;
[ANGS] [RGK] * [NKPT] * [ANGS]A; [MT]K* [QM] *QA; [KP] [NP] [KS] ** [AG]A;
[NM] * [NK] [NK] * [QT]G; [RK] **NT [GS]G; RN* [AN] [AN] *A;
N** [NQS] [RGK] [QGS]A; [KT] * [NGT] * [GSV] [ANST] [GS];
K* [NQM] [NG] [ANG] * [GP]; [NQ] * [AGK]G [QT] *G; QKN**SA (SEQ ID NO: 199966); Q*[NK]G* [AN]G; K[NT] *[AG] *QA; F*KT*QA (SEQ ID NO: 199967);
[NST]K[GPT] *G*G; RP*[ST]G*A (SEQ ID NO: 200024); PTK**SG (SEQ ID NO: 199968); R**QQNA (SEQ ID NO: 199969); QPK**GG (SEQ ID NO: 199970); KN*ST*A (SEQ ID NO: 199971); RQ*PT*A (SEQ ID NO: 199515);
K[NQG] *N* [AT]G; R[AN] [QS] * [AT] *G; [NQ] [RN] [GKP] [NQS] **A;
KP[GP]G**G (SEQ ID NO: 199972); KPS[NGS] **[AM]; RS*PG*A (SEQ ID NO: 199973); K*[NQT]ST*A (SEQ ID NO: 199974); [RK] *[NS] [AG]T*A;
KPSQ**P (SEQ ID NO: 199975); [NKM] *N* [GS] [NT]A; RSS*G*A (SEQ ID NO: 199976); RN*PG*G (SEQ ID NO: 199977); K[NQ] *[GS] *SG;
[NT] *K* [QPS] [NGS]A; N*RNT*P (SEQ ID NO: 199978); K* [NG]A* [QG]A;
K*GNQ*A (SEQ ID NO: 199979); S**STQS (SEQ ID NO: 199980);
NK**[GT]GG (SEQ ID NO: 199981); RN**NQA (SEQ ID NO: 199982);
NR**GQA (SEQ ID NO: 199983); K* [NT] [NS] *AA; [RK] [NT] *N*QA; NR*N*QG (SEQ ID NO: 199984); N**STMA (SEQ ID NO: 199669); N*KA*AG (SEQ ID NO: 199985); NKQ*A*A (SEQ ID NO: 199986); MKQ*G*G (SEQ ID NO: 199987); RGN*T*G (SEQ ID NO: 199988); K*NSS*P (SEQ ID NO: 199989);
K*NNP*A (SEQ ID NO: 199990); MKN*G*G (SEQ ID NO: 199991); RN*NG*G (SEQ ID NO: 199992); G*K*NVA (SEQ ID NO: 199993); K*GG*AG (SEQ ID NO: 199626); N**GTKG (SEQ ID NO: 199994); NN**NKG (SEQ ID NO: 199995); RDK**GG (SEQ ID NO: 199996); RQ*N*QG (SEQ ID NO: 199997);
SRTT*NG (SEQ ID NO: 199576); and TSKG**G (SEQ ID NO: 199998); or polynucleotides encoding the same, where “*” represents any amino acid, square brackets surrounding a list of amino acids not preceded by the symbol “{circumflex over ( )}” denote a list of amino acids that may occur at a position, and square brackets surrounding a list of amino acids preceded by the symbol “{circumflex over ( )}” denote a list of amino acids that may not occur at a position, wherein a viral particle having a capsid comprising the motif has reduced spleen biodistribution relative to a control viral particle.
wherein the capsid polypeptides are capable of forming viral particles with two or more of the following traits: 1) binding to liver cell; 2) transducing liver cell; and 3) biodistributing to the liver of an organism, and wherein the library comprises an amino acid sequence motif selected from the group consisting of:
[NQGIKT] [DGKFPS] [NEHKS] *[RDEHY] *[RQEKY];
[RDS] [DQE] *[RPT] [RNK] *[RKV];
[RDKMSY] ** [RNKSV] [ARDEP] [ARNDEIKS] [ARNKMYV]; Q [RE] ** [RK] [DI] [IK];
[NMT] [RDK] * [ARGTV] * [RDSY] [ANKT]; [GLFTY] * [HKY] * [NMPY] [NKS] [AQGL];
[ANGST] * [ADEG] [RNGH] * [RK] [RNESV];
[REKFY] [ARLTYV] [DGHKP] [RDHIKS] **[ARNEIFT];
[ANQKT] [ARKPS] [RGKM] ** [RSV] [DEGY]; [RMS] * [EK] * [RV] [DPT] [DKT];
[QY] *G*V[RK]G; [IPT] [DEGP]R[AQHV] **[ANK]; IRA**EK (SEQ ID NO: 199999); [DK] *R[NE] * [KT] [AQ]; [QI] [RD] *K[MP] * [RE]; D*KPR*Q (SEQ ID NO: 200000); [ST] [QY] [EK] * [RS] * [NK]; [EY] [ET] *K*RN; ILH**KN (SEQ ID NO: 200001); V*RSD*K (SEQ ID NO: 200002);
[ADE] [ADG] * [GK] *K[LMY]; [KV] [QLT]R* [DS] * [GI]; TD*KR*L (SEQ ID NO: 200003); [RELF] [EK] ** [AQ] [RD] [DGKS]; EK**TRQ (SEQ ID NO: 200004);
[MV] *R* [SV] [AD] [GK]; IL*H*KN (SEQ ID NO: 200005); V*KG*YN (SEQ ID NO: 200006); G**HKQL (SEQ ID NO: 200007); Y*SH*KG (SEQ ID NO: 200008); D[NK] [RH] [KV] ** [RV]; I*RS*TG (SEQ ID NO: 199859);
[IK] [GP]R*[DT] *[AG]; QGR*L*A (SEQ ID NO: 200009); YTS**KG (SEQ ID NO: 200010); G**ETRK (SEQ ID NO: 200011); V*RQ*AG (SEQ ID NO: 199782); DL*K*RA (SEQ ID NO: 200012); D*RPK*V (SEQ ID NO: 200013);
DR**VKQ (SEQ ID NO: 200014); G**TEKK (SEQ ID NO: 200015); I*R*MRE (SEQ ID NO: 200016); NDMR**K (SEQ ID NO: 200017); NE*KR*V (SEQ ID NO: 200018); QAR*E*R (SEQ ID NO: 200019); V*RS*GG (SEQ ID NO: 199791); YTE**KK (SEQ ID NO: 200020); or polynucleotides encoding the same, where “*” represents any amino acid and square brackets denote a list of amino acids that may occur at a position.

### Claim at position 22

32-80. (canceled)

### Claim 81 (depends on 1)

A composition comprising an adeno-associated virus (AAV) capsid of claim 1.

### Claim 82

(canceled)

### Claim 83 (depends on 14)

A method for screening a library of adeno-associated virus (AAV) capsid polypeptides for a trait of interest, the method comprising:
A) administering to an organism or contacting a population of cells with AAV particles comprising the library of claim 14;
B) identifying in the library those particles demonstrating the trait of interest in the organism and/or in/on the cells.

### Claim at position 26

84-89. (canceled)

### Claim 90 (depends on 19)

A viral particle identified by the method of claim 19.

### Claim 91 (depends on 8, 20)

A kit suitable for use in the method of claim 20, wherein the kit comprises adeno-associated virus (AAV) particles comprising the capsid polypeptides of claim 8, or polynucleotides encoding the same.
